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GENERAL INTRODUCTION 
The pig corpora lutea are the main source of both progesterone and relaxin during 
pregnancy and after hysterectomy (Anderson et al., 1983). Relaxin is primarily a hormone 
with important biological actions on the reproductive tract in mammalian species particularly 
near parturition. Some of the functions of relaxin include remodeling of the uterine and 
cervical connective tissues in preparation for the expulsion of the fetus. Relaxin also enhances 
the birth process resulting in an increased survival rate of the newborns (Nara et al., 1982). In 
the pig, progesterone is required for the maintenance of pregnancy throughout the 114 days of 
gestation. Plasma progesterone increases to peak concentrations by day 12 after mating and 
remains elevated until a few days before parturition, progesterone levels then decline to basal 
concentrations after delivery (Masuda et al., 1967; Robertson and King, 1974). Plasma 
relaxin concentrations are low in early pregnancy and gradually increase as pregnancy 
advances, this increase is correlated with the accumulation of electron-dense cytoplasmic 
granules in luteal tissue which are known to store relaxin (Belt et al., 1971; Anderson, 1982). 
Hysterectomy of nongravid pigs early in the luteal phase (days 6-8) maintains luteal 
fiinction until about day 150 (Anderson et al., 1983). Plasma relaxin and progesterone 
concentrations in hysterectomized gilts follow similar patterns to those of pregnant gilts at 
comparable reproductive stages (Felder et al., 1986). The mechanism(s) regulating the shifts 
in the release of progesterone and relaxin in late pregnancy is unknown. 
RU 486 is a potent antagonist of progesterone and it binds to the progesterone 
receptor (PR) with higher affinity than that of progesterone (Baulieu, 1985). The ability of 
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RU 486 to interact with the PR and antagonize progesterone function has been widely used as 
a tool in understanding steroid hormone function (Mao et al., 1992). RU 486 is currently 
being studied as a potential compound for prevention of implantation and termination of early 
pregnancy in women (Baulieu, 1989). The antagonistic property of RU 486 has also been 
used to induce delivery in cattle (Li et al., 1991b), pigs (Li et al., 1991a), and sheep (Gazal et 
al., 1993). Hormone treatment involving RU 486 can be used as a calving management tool 
to precisely time delivery in farm animals. The objectives of the present studies were: 1) to 
examine the hormone profiles during late pregnancy and early lactation in pigs, 2) to 
determine the effect of immunization against endogenous relaxin on parturition in pigs, and 3) 
to investigate the effects of RU 486 treatment alone or in combination with relaxin on 
parturition in first-calf beef heifers. 
Dissertation Organization 
The dissertation begins with a GENERAL INTRODUCTION, a LITERATURE 
REVIEW of relevant topics to this research is presented next. Following the 
LITERATURE REVIEW are three complete papers and each paper includes abstract, 
introduction, materials and methods, results, discussion and references. Major conclusions 
and proposed further research is covered in the GENERAL SUMMARY. Lastly, a section 
titled ADDITIONAL REFERENCES lists references cited in the LITERATURE 
REVIEW. 
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LITERATURE REVIEW 
Relaxin in Reproduction 
Since the discovery of relaxin by Hisaw in 1926, significant advances have been made 
in establishing the role of relaxin in mammalian reproduction. The preparation of pure relaxin 
by Sherwood and O'Byme (1974) was central to understanding the biological actions of this 
hormone in a number of mammalian species. Porcine relaxin is a peptide hormone with a 
molecular weight of 6000 daltons. It consists of dissimilar A and B chains joined by two 
disulfide bonds, the A chain has an additional intradisulfide bond (Schwabe et al., 1976; 
James et al., 1977). Structurally, relaxin is related to insulin and the insulin-like grov^h 
factors (IGFs) (James et al., 1977; Schwabe and Harmon, 1978; Haley et al, 1987). Relaxin 
is primarily known as a hormone of pregnancy with biological actions on the connective tissue 
of the reproductive tract, mammary gland development and is also involved in parturition 
(Sherwood, 1988). 
Recent reports suggest that relaxin may be involved in the regulation of blood pressure 
(St-Louis and Massicotte, 1985; Mumford et al., 1989; Parry et al., 1990), heart rate 
(Kakouris et al., 1992; Ward et al., 1992), and the release of oxytocin and vasopressin 
(Summerlee et al., 1984, 87; Jones and Summerlee, 1987; Dayanithi et al., 1987; Way and 
Leng, 1992) by acting either through the central nervous system (CNS) or peripherally. 
Relaxin infused at a low dose (1.8^g/day) in non-pregnant rats, using an osmotic mini-pump, 
induced a decrease in blood pressure comparable in magnitude to that observed in pregnant 
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rats (St-Louis and Massicotte, 1985). However, relaxin administered in the third ventricle of 
the brain caused a marked increase in systemic blood pressure in anaesthetized rats (Mumford 
et al., 1989; Parry et al., 1990). The effects of relaxin on the mammalian heart have been 
reported by Ward et al. (1992) and Kakouris et al. (1992) where treatment of isolated rat atria 
wdth human relaxin increased the rate and force of contraction of this cardiac tissue. Ward et 
al. (1992) fiirther demonstrated that relaxin in vivo also increased the rate and force of 
contraction in rat cardiac atria. Relaxin receptors have been found in adult rat brains and 
hearts (OsheroflFand Ho, 1993). These studies concluded that relaxin may have a role during 
pregnancy in humans where increased heart rate may be essential to prepare for the increase in 
cardiac load necessitated by growth of the uterus and fetus. 
The release of neuropeptides like oxytocin and vasopressin has been shown to be 
regulated by relaxin (Kato, 1978; Dayanithi et al., 1987). In these studies, relaxin inhibited 
oxytocin and vasopressin release under basal conditions, however when nerve endings were 
depolarized, vasopressin and oxytocin secretion was stimulated. In anaesthetized lactating 
rats, intravenous injection of porcine relaxin inhibited milk ejection and injection of relaxin 
into the cerebral ventricles disturbed the pattern of the milk ejection reflex (Summerlee et al., 
1984, 87; Jones and Summerlee, 1987). In contrast, porcine relaxin administered 
intravenously caused a sustained increase in circulating plasma oxytocin and vasopressin 
concentrations (Way and Leng, 1992). 
The primary source of relaxin in the pig (Fevold et al., 1930; Belt et al., 1971), rat 
(Anderson et al., 1973, 75, 78), and cow (Fields et al., 1980; Anderson, 1982; Fields et al.. 
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1982) is the corpus luteum of pregnancy. However in recent studies the porcine ovarian 
follicle has been identified as a secondary source of relaxin (Matsumoto and Chamly, 1980; 
Bryant-Greewood et al, 1980). The thecal layer of preovulatory follicles obtained from 
prepubertal pigs, primed with pregnant mare serum gonadotropins or human chorionic 
gonadotropin, secreted modest quantities of relaxin (Bagnell et al., 1987, 91). These studies 
also showed that after luteinization granulosa cells are capable of relaxin production. 
Furthermore, the finding that the pig ovarian follicle produces relaxin led to the speculation by 
these authors that relaxin may have a paracrine role in the ovulatory process. 
Using immunohistochemical techniques to examine the corpus luteum of the pregnant 
pig several researchers reported that relaxin immunoactivity was associated with membrane-
bound cytoplasmic granules found within the luteal cells(Belt et al., 1971; Fields and Fields, 
1985; Denning-Kendall et al., 1989). These studies demonstrated that there was an 
association between relaxin plasma concentration and the presence and/or absence of the 
cytoplasmic granules. The corpora lutea of the pregnant pig and that of gilts hysterectomized 
during the estrous cycle reach maximum size (>450mg) by day 8 and these corpora lutea 
produce both relaxin and progesterone (Anderson et al., 1973, 83; Adair et al., 1989). The 
profiles of relaxin concentrations in hysterectomized unmated gilts and in gilts experiencing 
normal pregnancy increased at similar rates as the age of corpora lutea advanced (Belt et al., 
1971; Anderson et al., 1983). On the other hand, progesterone plasma concentrations in 
hysterectomized pigs remained consistently greater than that observed during corresponding 
stages of normal pregnancy (Adair et al., 1989; Musah et al., 1984). The prepartum relaxin 
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surge observed in peripheral blood (Felder et al., 1986) is consistent with the view that relaxin 
accumulates within corpora lutea during pregnancy and is secreted a few days before 
parturition (Belt et al., 1981). Relaxin concentrations increased markedly and attained 
maximal levels in both hysterectomized and pregnant pigs 2 days before parturition 
(Sherwood et al., 1981; Felder et al., 1986, 88; Li et al., 1991a). The actual maximal relaxin 
peak generally occurs 24 to 14 h before parturition (Wathes et al., 1989; Li et al., 1991a), 
thereafter relaxin levels decline rapidly to about 10 ng/ml at birth and by 24 to 48 hours after 
parturition relaxin levels are less than 1 ng/ml (Sherwood et al., 1975; Felder et al, 1988). 
The prepartum relaxin surge in the pig appears to be associated with luteolysis, there is a 
marked decline in plasma progesterone concentration during the 2 days which precede 
parturition (Ash and Heap, 1975; Sherwood et al., 1981; Felder et al, 1986). The 
mechanism(s) involved in both the initiation of luteolysis and the prepartum relaxin surge 
observed near parturition in the pig is not well understood. Studies using fetal decapitation 
(Sherwood, 1982) and fetal hypophysectomy (Kendall et al, 1988) have shown that the 
association between the prepartum surge of relaxin and delivery is disrupted by these 
operations, the interval between the relaxin surge and delivery was 10 to 12 days. Other 
studies (Felder et al, 1986; Li et al, 1991a) suggest that luteolysis and relaxin release may be 
independent of fetal control. In recent studies (Felder et al., 1988; Li et al, 1991a), where the 
lifespan of corpora lutea was extended by hysterectomizing pigs at 6-8 days of a normal 
estrous cycle, there was precise timing of the decline in progesterone levels and the surge in 
relaxin levels in peripheral plasma which was similar to the timing of these events in pregnant 
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pigs. The sudden shifts in relaxin and progesterone levels in peripheral plasma on days 110-
113 in both hysterectomized and pregnant gilts were suggested to be regulated autonomously 
from within the ovary or by the CNS and pituitary glands (Felder et al., 1986). However, it is 
worth mentioning that in hysterectomized gilts the progesterone and relaxin levels decline less 
abruptly and had higher basal levels than those in postpartum pigs at comparable times (Felder 
et al., 1988; Li et al., 1991a). In pregnant pigs the decline in peripheral blood of progesterone 
and relaxin in these studies was abrupt, the postpartum basal levels were attained 48 hours 
after parturition. The elevation in relaxin plasma concentration that occurs several days 
before farrowing may be involved in preparation of the reproductive system for delivery. 
Eldridge-White et al. (1989) reported increased levels of estrogen and relaxin after day 100 in 
pregnant pigs and suggested that these hormones are involved in cervical dilation near 
parturition. This view is also supported by Nara et al. (1982) who demonstrated that relaxin 
is required for short term delivery of piglets and high survival rate of newborn pigs in 
ovariectomized pregnant pigs. 
In attempting to establish the factors responsible for the prepartum surge in relaxin 
levels, a number of studies have been undertaken (Nara and First, 1981; Kendall et al., 1982; 
King and Wathes, 1989). Pituitary prolactin (PRL) does not appear to influence either 
luteolysis or the antepartum relaxin release, porcine PRL administration from days 110-120 to 
hysterectomized gihs (Felder et al., 1988) or hysterectomized plus hypophysectomized gilts 
elevated plasma relaxin and progesterone levels compared with control gilts (Li et al., 1989). 
Additional evidence that supports the premise that PRL is not involved in luteolysis near 
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parturition is that administration of bromocriptine suppressed the prepartum PRL surge but 
had no effect on the antepartum relaxin surge in pregnant pigs (Taveme et al., 1982). It 
appears that prostaglandins play a role in luteolysis and the antepartum surge in relaxin levels. 
Sherwood et al. (1979) reported that prolonged prostaglandin F2« (PGF2a) infusion on day 
110 of pregnancy in the pig or intramuscular injection of prostaglandin on day 112 (King and 
Wathes, 1989; Widowski et al., 1990) induced parturition within 30 hours and initiated 
luteolysis and a surge in relaxin concentration in peripheral blood. These events which were 
induced by the infusion of PGF2a (relaxin surge and decline in progesterone level) resemble 
what occurs near parturition in the pig. The suggested involvement of prostaglandin in the 
initiation of luteolysis and antepartum surge in relaxin levels is further reported in several 
studies (Sherwood et al., 1979; Nara and First, 1981; Taveme et al., 1982). These studies 
concluded that inhibition of prostaglandin synthesis by administration of endomethacin during 
late pregnancy delayed not only luteolysis and relaxin surge, but it also prolonged gestation 
until 2 to 5 days after treatment was terminated. The prostaglandin produced by the uterus is 
probably not involved in luteolysis and the relaxin surge, Gooneratne et al. (1983) found that 
the peak of the PGF2a metabolite, 13, 14 dihydro-15-keto PGF2a occurs on the day of 
parturition several days after the decline in the progesterone levels and surge in relaxin prior 
to delivery. It is possible, however, that the initial rise in uterine PGF2a is sufficient to 
trigger luteolysis and relaxin secretion, and this may be supported by the difference in 
progesterone concentrations between hysterectomized versus pregnant pigs at parturition 
(Felder et al., 1986). Prostaglandin synthesized by corpora lutea is also a potential luteolytic 
9 
signal that triggers luteolysis and the release of relaxin (Patek and Watson, 1983). During 
lactation in the pig, the corpora lutea are capable of producing small amounts of relaxin 
(Anderson et al, 1973; Bagnell et al., 1990). The similarity of the events in lactating and 
hysterectomized animals makes the hysterectomized pig an interesting model in studying the 
mechanism(s) involved in the regulation of hormonal events that lead to parturition in the pig. 
Reproductive tract changes during pregnancy and parturition 
The association of the hormone relaxin with reproduction particularly in mid to late 
pregnancy is well established (Sherwood, 1988). Studies conducted to examine the effects of 
highly purified relaxin in pregnant animals have shown that relaxin stimulates growth and 
softening of the cervix in pigs (Kertiles and Anderson, 1979; Eldridge-White et al., 1989; 
O'Day et al., 1989; Winn et al., 1993) and rats (Downing and Sherwood, 1985). Similar 
properties of relaxin were observed in cattle (Perezgrovas and Anderson, 1982; Musah et al., 
1988), in these studies relaxin administration during late pregnancy promoted increased pelvic 
area and facilitated earlier calving in treated animals compared with untreated controls. O'Day 
et al. (1989) reported that relaxin has growth-promoting properties on the cervix during late 
pregnancy. In this study, pregnant gilts were ovariectomized on day 100 and given 
replacement therapy for 10 days with progesterone and porcine relaxin in doses similar to 
those observed in intact pregnant controls, the wet weight and lumen diameter of the cervix 
were similar to intact controls. However, when ovariectomized gilts were administered with 
progesterone in doses similar to intact control animals, cervical wet weight and lumen 
diameter were not affected. To better understand the role of relaxin during late pregnancy, 
Winn et al. (1992) treated ovariectomized postpubertal nonpregnant gilts with progesterone, 
estrogen and porcine relaxin alone or in various combinations from day 100 to 110 of 
pregnancy, their findings also demonstrated that progesterone and relaxin work in synergy to 
promote increased wet weight and lumen diameter of the uterine portion of the cervix. This 
also showed that even though estrogen promotes cervical distensibility, these effects were 
independent of relaxin activity. Subsequent work by Winn et al. (1993) again demonstrated 
that progesterone augments the action of relaxin during late pregnancy in the pig. The effects 
of relaxin on the uterine tissue are of two functionally different categories. First, relaxin has 
been shown as an inhibitor of uterine contractions both in vivo and in vitro and that estrogen 
and progesterone are involved in the modulation of this relaxin effect (Downing and 
Hollingsworth, 1993). Second, there is evidence that relaxin has uterotrophic effects in the 
rat (Vasilenko et al., 1986, 87) and pig (Hall et al., 1990, 92). In rats, relaxin treatment 
promoted growth of the uterus, cervix and vagina (Vasilenko and Mead, 1987), the growth of 
these reproductive organs was attributed to increased water content and increase in actual 
tissue mass. The connective tissue of both the endometrium and myometrium in rats after 
treatment with relaxin was reported to assume a loose arrangement with randomly organized 
and less dense collagen fibers; in contrast, control rats had relatively dense and organized 
uterine collagen fibers that were closely associated (Vasilenko et al., 1986). This study also 
concluded that relaxin treatment greatly improved vascularization of the uterine tissue, and 
suggested that the increase in vascularization may be the mode by which relaxin elicits its 
uterotrophic effects. 
Similar relaxin effects appear to be involved in the growth of the uterine tissue in the 
pig, when prepubertal gihs were treated with relaxin (Hall et al., 1990), there was increased 
uterine dry weight, increased protein accumulation by uterine tissue, increased water 
imbibition and improved DNA content. In a subsequent study, Hall et al. (1992) further 
demonstrated that the effects of relaxin on uterine growth are dependent on steroid hormone 
milieu. The authors in this study suggested a synergistic mechanism between relaxin and 
estrogen in the presence of progesterone. In the pig (Mercado-Simmen et al., 1982a) and rat 
(Mercado-Simmen 1982b) estrogen was reported to modulate relaxin receptors in the uterus. 
These findings led them to conclude that estrogen enhances uterine tissue response to relaxin 
via increased relaxin receptors. Major relaxin-induced changes were observed by Hurley et 
al.(1991), when ovariectomized late pregnant gilts were given a replacement therapy of 
relaxin and progesterone; there was induced mammary parenchyma development similar to 
intact control animals. This finding is in agreement with a study by Hwang et al. (1991) where 
rats positively immunized against endogenous relaxin in the second half of pregnancy failed to 
develop nipples and mammary glands. In addition, lack of relaxin needed for mammary 
development reduced both growth and survival rate of the pups during lactation. 
The physiological role of relaxin in the reproductive tract near parturition is further 
confirmed by Guico-Lamm and Sherwood (1988), who passively immunized pregnant rats on 
days 12 to 22 with monoclonal antibody (MCAl) specific for rat relaxin (Guico-Lanun et al.. 
1988b), observed that MCAl-treated rats had prolonged durations of straining with reduced 
survival rate of pups compared with PBS-treated control rats. Furthermore, this study 
reported that MCAl-treated pregnant rats experienced higher cases of retained fetuses and 
placentae than PBS-treated pregnant rats. The cause of this parturition problems was 
attributable to less extensible cervices in MCAl-treated rats compared with cervices from 
PBS-treated controls (Hwang and Sherwood, 1988). These findings suggest that endogenous 
relaxin is critical for ease of parturition and also promotes neonatal survival of the newborn in 
the rat (Hwang et al., 1989). 
Several studies have reported involvement of relaxin in various activities during late 
pregnancy and parturition in a number of species. In pregnant pigs that were ovariectomized 
or luteoectomized and given a replacement therapy of progesterone on subsequent induction 
of parturition, the relaxin deficient group had longer delivery times with higher incidence of 
stillbirths (Kertiles and Anderson, 1979; Nara et al., 1982). These resuUs provide evidence 
that relaxin is not only essential for normal duration of parturition but is also important in 
promoting neonatal survival. Similar work with cattle (Musah et al., 1986, 87; Bagna et al., 
1991) is consistent with the role of relaxin as a hormone that facilitates parturition and 
survival of the newborn. It is surprising, however, that there is evidence that points to 
increasing delivery time when relaxin concentrations are high (Wathes et al., 1989) even 
though the increase in delivery time had no adverse effects on neonatal survival. In the rat, 
there is evidence that relaxin inhibits parturition by acting centrally to suppress oxytocin 
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release (Jones and Summerlee, 1986) and that this oxytocin inhibition is reversed by naloxone 
treatment. 
Progesterone secreted by corpora lutea is indispensable for the maintenance of 
pregnancy throughout the 114 days of gestation in the sow (Bazer and First, 1983). Once 
formed, these corpora lutea are capable of producing progesterone without luteotropic 
support for the first 14 days of pregnancy, interruptions such as hypophysectomy are 
ineffective during this period (Anderson et al., 1967; Bazer and First, 1983). Beyond this 
period of pregnancy, luteinizing hormone and PRL become increasingly important in the 
maintenance of progesterone secretion by corpora lutea (Bazer and First, 1983; Szafranska 
and Tilton, 1993). It is clear, therefore, that dramatic hormonal changes including a decline in 
progesterone levels are necessary for the. initiation of parturition. 
Role of prolactin in pregnancy and parturition 
PRL is generally known as a hormone involved in lactation, this is, however, a narrow 
view of the function of this hormone. It is clear from recent evidence that PRL has other roles 
in the regulation of reproduction in mammalian species (Dusza and Tilton, 1990). In the pig, 
the maintenance of pregnancy is dependent on progesterone produced by corpora lutea. The 
maintenance of luteal function in the second half of pregnancy in the pig appears to be 
associated with PRL as a luteotropic hormone (Szafranska and Tilton, 1993). The finding 
that specific PRL binding in the pig corpus luteum was low in early and late luteal phases but 
significantly higher in the mid-luteal phase (Bramley and Menzies, 1987) demonstrates the 
importance of PRL for normal luteal function. This study also reported that during pregnancy 
in the pig there is substantial increase in the PRL receptor concentration which correlates with 
increasing gestational age, however PRL receptors declined after parturition. Jammes et al. 
(1985) reported increased prolactin and LH receptor contents in corpora lutea of pregnant 
pigs, but PRL receptors increased before LH receptors indicating that PRL may be involved in 
the induction of LH receptors. In the same study, PRL and LH receptor numbers in ewes 
remained relatively unchanged throughout pregnancy. 
Administration of PRL from day 110 to 120 in hysterectomized gilts stimulated and 
extended the preprogrammed release of relaxin and maintained progesterone secretion by 
aging corpora lutea (Felder et al., 1988). Subsequent work by Li et al. (1989) using 
hysterectomized gilts after hypophysectomy demonstrated that PRL administration maintained 
both relaxin and progesterone secretion by aging corpora lutea. Hyperprolactinaemia in 
pregnant pigs after blocking Dj and I>2 receptors with haloperidol resulted in decreased LH 
levels but did not affect progesterone concentration in haloperidol-treated versus vehicle-
treated controls (Szafranska and Tilton, 1993). This finding led these investigators to 
conclude that PRL has a more critical luteotrophic role in the second half of pregnancy in pigs 
than previously believed, the mechanism(s) by which PRL elicits its actions is, however, 
unclear. Bromocriptine administration to late pregnant pigs decreased PRL concentration but 
did not change progesterone secretion despite a marked rise in LH plasma concentration 
(Szafranska and Ziecik, 1990). The prepartum PRL concentration begins to increase three 
days before delivery and reaches peak concentration at the time of delivery (Taveme et al.. 
1979; Kendall et al., 1982). When bromocriptine injection was performed at delivery, 
lactation was blocked but delivery was normal (Taveme et al., 1982) suggesting that the 
prepartum PRL rise is associated with onset of lactation. The high PRL concentration 
observed at parturition declines gradually as lactation proceeds but remains higher than the 
basal levels typically observed during the follicular phase of the estrous cycle (Dusza and 
Krzymowska, 1981). 
The role of growth hormone during pregnancy and lactation 
The part played by growth hormone (GH) when administered over short periods of 
time during late pregnancy and/or lactation has been reported in cattle (Peel et al., 1982; 
McDowell et al., 1987), sheep (McDowell et al, 1988); Sandles et al., 1988), rats (Jahn et al., 
1993) and pigs (Farmer et al., 1992). In all these studies, there is a consistent finding that GH 
alters nutrient utilization in muscle and mammary tissue in a manner that favors increased 
nutrient supply for milk synthesis. Jahn et al. (1993) reported a marked increase in plasma 
GH concentration in rats 4 days before parturition and suggested that this increase in GH may 
be responsible for the final mammary gland differentiation before the initiation of lactation. 
This increase in GH may also be associated with the dramatic increase in PRL receptors in the 
mammary gland at the end of pregnancy in the rat (Jahn et al., 1991). In the ewe, GH not 
only promotes blood flow in tissues to supply additional metabolites to the mammary gland, 
but it also stimulates processes that spare glucose oxidation, for example, increased oxidation 
of non-sterified fatty acids (McDowell et al., 1988; Sandles et al., 1988). When growth 
hormone-releasing factor (GRF) was administered to pigs in late pregnancy and early 
parturition (Farmer et al., 1992), there was improved utilization of protein sources by lactating 
pigs. It appears that GH has a support function particularly in processes that eventually lead 
to successful lactation. In pregnant rats, there is a marked increase in GH 3 days before the 
steep increase in PRL levels suggesting that GH hormone may be involved in the initiation of 
lactation (Jahn et al., 1993). 
Relaxin administration in both beef (Musah et al., 1986) and dairy (Bagna et al., 
1991) heifers during late pregnancy promotes an increase in pelvic area, ceivical distensibility 
and facilitates earlier calving. The increase in pelvic area may be, to a large degree, due to 
relaxation of the pelvic ligaments and remodeling of the pelvic symphysis (Musah et al., 
1986). The pelvic area and calf size relationship (main factors determining occurrence of 
dystocia) at parturition is of tremendous economic value because it determines not only 
chances of survival of the newborn, but also subsequent reproductive performance of the dam 
(Laster et al., 1973; Price and Wiltbank, 1978). Heifers calving at 2-years of age are more 
susceptible to dystocia than 3-year old heifers and they also experience higher incidence of 
retained placenta (Laster et al., 1973). Two-year old heifers have less well developed pelvic 
area and are less able to recover from the traumatic events experienced at calving. The 
problem of retained placenta inflates the reproduction costs of the producer and is also a 
source of cow infertility (Paisley et al., 1986). Management decisions that will reduce the 
incidence of retained placenta are essential for a sustained efficiency in reproductive 
performance of the herd. Musah et al. (1987) found that administration of relaxin combined 
with cloprostenol or dexamethasone reduces both the incidence of retained placenta, and also 
shortens the period of delivery in late pregnant beef heifers. 
Mifepristone (RU 486) is a synthetic steroid which has both antiprogesterone and 
antiglucocorticoid activity, it also has potential use in a variety of physiological and clinical 
conditions (Baulieu, 1987). Because of its antiprogesterone properties, RU 486 has been 
widely used as an abortifacient (Avrech et al., 1991; Glasier et al., 1992), antiovulatory drug 
(Liu et al., 1987; Luukkainen et al., 1988; Danforth et al., 1989) and an inducer of 
endometrial bleeding (Garzo et al., 1988; Swahn et al., 1990). The ability of RU 486 to bind 
to the same receptor as progesterone has provided researchers with an enormous analytical 
tool to study the mechanism(s) by which steroid hormones manifest their actions at the 
cellular level. The advances made in understanding the mechanism of steroid hormone action 
by using antiprogestogens to date are encouraging. Recent studies (Gravanis et al., 1985; 
Koering et al., 1986), however, have also demonstrated that RU 486 has some progestational 
(agonistic) activity under limited progesterone concentration and/or at low progesterone 
receptor concentrations. 
Progesterone in mammalian species is responsible for the preparation of the 
endometrium for implantation in early pregnancy. Withdrawal of progesterone by luteectomy 
induces spontaneous abortion because of lack of secretory endometrial development (Csapo et 
al., 1973). In cattle, progesterone has a role in maternal regulation of growth and 
development of the fetus in early pregnancy (Garret et al., 1988). Administration of 
progesterone early in the estrous cycle resuhs in a shorter interestrus interval in the cow 
(Ginther, 1970; Battista et al., 1984) and ewe (Ottobre et al., 1980; Lawson and Cahill, 1983). 
It has been suggested that this shortening of the estrous cycle is due to a hastened release of 
prostaglandin F2a from the uterine endometrium (Garrett et al., 1987). This exposure of the 
reproductive system to progesterone early in the estrous cycle was found to advance uterine 
secretory development (Ottobre et al., 1980). It is clear from these studies that progesterone 
is necessary not only for the control of the length of the estrous cycle, but also for successful 
implantation in early pregnancy. 
RU 486 binds to the progesterone receptor with higher affinity than that of 
progesterone (Baulieu, 1989; Beck et al., 1993). As a class, steroid hormones are capable of 
entering the target cell and interact with receptors believed to be largely if not entirely 
localized in the cell nucleus. Because RU 486 is a steroid, like steroid hormones it can 
traverse the cell membrane to interact with nuclear receptors. Steroid receptors in general 
have three common structural domains which have specialized functions namely hormone 
binding, DNA binding, and gene activation (Carson-Jurica et al., 1990). In the absence of 
steroid hormone the steroid receptor is associated with heat shock protein-90 (HSP-90) which 
renders the receptor inactive by giving it a stable orientation termed 8-10s complex (Kost et 
al., 1989; Pratt, 1990). This association with HSP-90 prevents the DNA binding activity of the 
receptor. It is this association of the receptor with HSP-90 that is reversed by hormone 
binding and the state of the receptor is changed from inactive 8-10s to active 4s state. 
Dissociation of HSP-90 also facilitates the DNA binding activity of the receptor (Pratt, 1987). 
The hormonal ligand activated receptors then bind to hormone response elements (HRE) of 
DNA which stimulate transcription of regulated genes (Carson-Jurica et al., 1990; Bagchi et 
al., 1992). The steroid hormone receptors are phosphoproteins (Dinner et al., 1987; Singh 
and Moudgil, 1985), it is not surprising, therefore, that phosphorylation-dephosphorylation is 
the proposed control mechanism for the regulation of receptor activity (Migliaccio and 
Auricchio, 1981). In the inactive state, HSP-90 binds to the hormone binding domain of the 
receptor (Carson-Jurica et al., 1990). In addition, there is another hypothesis that suggests 
that HSP-90 also musks the DNA binding domain of the steroid receptor (Binart et al., 1989) 
to keep it inactive. The ability of RU 486 to bind and exhibit anti-steroid-like properties in 
vivo has provided an aUemative pharmaceutical tool to combat various physiological effects 
of steroid hormones (Horwitz, 1992). For example, the mitogenic action of progesterone in 
breast cancer is counteracted by blocking endogenous progesterone with antiprogestin (RU 
486). There is however different views on the molecular basis of how RU 486 antagonizes 
hormonal activity. One hypothesis suggests that RU 486 inhibits steroid receptor activation by 
preventing the dissociation of HSP-90 from the inactive receptor (Baulieu, 1988). This then 
helps to stabilize the non-active 8s-form of steroid receptor where the DNA binding site is 
occupied by HSP-90 (Renoir et al., 1989). Another hypothesis resuhs from evidence of RU 
486 acting at a step beyond the stabilization of HSP-90 and preventing DNA binding activity. 
Bagchi et al. (1988) demonstrated that RU 486, when complexed with a progesterone 
receptor in the cytosol or nuclear extract of human breast cancer (T47D) cells, binds to a 
progesterone regulatory element with high affinity. New evidence has emerged reporting 
conformational differences between RU 486-and agonist-bound receptors (El-ashry et al.. 
1989; Skafar, 1990) this implies that stmctural alteration may be the mode of action of 
antiprogestins (RU 486) to prevent transcriptional activity. Administration of RU 486 in the 
follicular phase of the estrous cycle in the human interrupts normal follicular development (Liu 
et al., 1987) and extends the estrous cycle length. These authors speculate that disruption of 
follicular growth may have been caused by the slight decrease in gonadotropins released 
observed after RU 486 treatment. In contrast, RU 486 treatment in the mid-luteal phase 
induced menstrual bleeding in women (Niemen et al., 1987) and monkeys (Asch and Rojas, 
1985). The uterine bleeding occurs with or without luteal regression indicating a direct RU 
486 action on the endometrial tissue (Schaison et al., 1985). Morgan et al. (1993) injected 
ewes with RU 486 during the early luteal phase of the estrous cycle and caused failure of 
luteolysis. The absence of luteolysis was attributed to inadequate PG F2a release, and the 
interestrus interval of RU 486-treated sheep was extended. The menstrual cycle length was 
also extended when monkeys were treated with mifepristone (RU 486) on day 10-20 of the 
estrous cycle (Collins and Hodgen, 1986). The extension of the estrous cycle and the delayed 
subsequent follicular development in this study was caused by the suppressed mid cycle LH 
surge. 
Treatment of women in early pregnancy with RU 486 results in abortion (Avrech et 
al., 1991), and this is accomplished by blocking progesterone effects at the receptor level in 
the endometrium. The mechanism by which RU 486 induces termination of pregnancy is not 
well understood. There is evidence that RU 486 may cause abortion by decreasing PR 
concentration. The abortifacient effect of RU 486 could also be caused by PR- and ER 
21 
concentration changes that favor increased ER and decreased PR concentration (Zaytseva et 
al., 1993). When RU 486 is given during late pregnancy in the rat (Bosc et al., 1987), ewe 
(Burgess et al., 1992; Gazal et al., 1993), sow (Li et al., 1991a) and cow (Li et al, 1991b) 
parturition occurs earlier than in control animals. The main cause of the enhanced delivery is 
the withdrawal of progesterone dominance and allowing physiological actions that will trigger 
the expulsion of the fetuse(s). It appears that the combined effects of RU 486 and relaxin in 
controlling parturition in late pregnant cattle promote survival rate of newborn calves with 
reduced incidence of dystocia, retained placenta, and delayed postpartum fertility. 
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HORMONE PROFn.ES IN CHINESE MEISHAN GILTS DURING LATE 
PREGNANCY AND AFTER HYSTERECTOMY 
A paper to be submitted to the Journal of Animal Science 
B, J. Dlamini, Y. Li, J. Klindt and L. L. Anderson 
Abstract 
Pregnant and hysterectomized Meishan gilts were used to investigate the production 
and secretion of relaxin, progesterone, prolactin and grov^^h hormone during different 
reproductive states. Six gilts were bred to Meishan boars on the first day of the second 
observed estrus and unmated gihs were hysterectomized on days 6-8 (estrus = day 0). Blood 
samples (10 ml) were collected twice daily (0800 and 2000 h) fi"om d 90 to 120 and every 20 
min within a 3-h period on days 112-116. From days 99 to 109 relaxin concentrations 
remained consistently greater (6 ± 1.0 ng/ml) in hysterectomized compared with pregnant (2 
± 0.4 ng/ml, P < 0.05) gilts. Relaxin concentrations peaked on day 114 in both pregnant (66 
± 10.9 ng/ml) and hysterectomized (34 ± 4.2 ng/ml) gihs, by day 1 postpartum relaxin 
concentration decreased fi'om a peak of 66 ± 10.9 ng/ml to 1 ± 0.3 ng/ml and remained low 
until day 120. In hysterectomized gilts, relaxin levels declined sharply fi-om a peak of 34 ± 
4.2 ng/ml to 13 ± 3.2 ng/ml within a day but remained higher (P < 0.05) than in lactating pigs 
until day 120. Peripheral plasma progesterone concentrations were higher (P < 0.05) in 
hysterectomized compared with pregnant pigs from days 99 to 109. Progesterone levels 
decreased by half from day 109 to day 115 and remained at 16 ng/ml until day 120 in 
hysterectomized pigs. The decline in progesterone levels in hysterectomized pigs coincided 
with the marked decline observed before parturition in pregnant pigs. Prolactin concentration 
in hysterectomized gilts remained low (4 ±0.8 ng/ml) throughout the period of the study, 
whereas in pregnant gilts PRL levels increased steadily from 16 ±0.8 ng/ml on day 99 to 39 
±10 ng/ml at parturition (day 114) and remained at high concentrations during lactation. 
Growth hormone levels were similar in hysterectomized and pregnant gihs from day 99 to day 
114, however GH concentrations were consistently higher (P < 0.05) in lactating compared 
with hysterectomized gilts (2.6 ± 0.6 vs 1.0 ± 0.3 ng/ml, respectively). This study confirms 
the study by Felder et al. (1986) who showed that in pregnant pigs there is a timed peak 
relaxin release that coincides with a decline in progesterone secretion and a similar secretory 
pattern of these hormones is observed in hysterectomized pigs at comparable times. The 
study further suggests that PRL and GH secretions are different in pregnant and 
hysterectomized pigs probably because of the physiological changes necessitated by the onset 
of lactation. The adinohypophyseal secretion of PRL and GH together with the shift in relaxin 
and progesterone secretions near parturition implies that the ovary, central nervous system 
and the pituitary glands may have roles in the regulation of the hormone secreted during late 
pregnancy and early lactation in the pig. 
Introduction 
The production of relaxin and progesterone by corpora lutea in the pig occurs during 
normal estrogen cycle (Sherwood and Rutherford, 1981), pregnancy (Anderson et al., 1973, 
83) and after hysterectomy (Anderson et al., 1983). Relaxin is primarily known as a hormone 
with important physiological roles on the reproductive tract particularly near parturition, some 
of the principal functions being to enhance the birth process and also to increase the survival 
rate of the newborn (Nara et al., 1982). There are, however, recent reports that show that 
relaxin is involved in other biological actions that are not directly related to reproduction (St-
Louis and Massicotte, 1985; Kakouris et al., 1992). In the pig, progesterone is required for 
the maintenance of pregnancy while relaxin is of particular importance for normal delivery of 
the young. Blood concentrations of progesterone increased to peak values by day 12 after 
mating and remain elevated until a few days before parturition, thereafter progesterone levels 
decline to basal concentrations (Masuda et al., 1967; Robertson and King, 1974). Peripheral 
plasma relaxin concentrations are detectable during early pregnancy and a sustained steady 
increase of this hormone is observed as pregnancy advances, this increase is correlated with 
the accumulation of electron-dense cytoplasmic granules in luteal tissue which are known to 
store relaxin (Belt et al., 1971; Sherwood et al., 1975). Depletion of the electron-dense 
cytoplasmic granules coincides with the prepartum peak release of relaxin (Sherwood et al., 
1981; Felder et al., 1986). 
Hysterectomy of nongravid pigs early in the luteal phase (day 6-8) maintains luteal 
function until about day 150 (Anderson et al., 1983; Musah et al., 1984). Peripheral plasma 
levels of both progesterone and relaxin in hysterectomized gilts follow similar patterns to 
those of pregnant gilts at comparable stages (Sherwood et al., 1981; Anderson et al., 1983). 
PRL has biological actions in a number of organs, in mammals it appears that the fiindamental 
function of PRL is the regulation of reproduction (Jahn et al., 1991). Several studies have 
demonstrated that PRL is luteotrophic in the pig (Bramely and Menzies, 1987; Szafranska and 
Tilton, 1993). 
The GH concentration increase during lactation has been shown to alter nutrient 
utilization in muscle and mammary tissue in a manner that favors increased nutrient supply for 
milk synthesis (McDowell et al., 1987; Jahn et al., 1993). The hysterectomized pig model has 
been used to investigate mechanisms that regulate secretion of relaxin and progesterone by 
aging corpora lutea in Yorkshire gilts (Felder et al., 1986). The overall objective of this study 
was to examine hormone profiles in Chinese Meishan pigs during different reproductive states. 
Specifically, the present study investigates: 1) relaxin and progesterone secretion relationship 
by corpora lutea during late pregnancy and early parturition and 2) adenohypophysial 
secretion of PRL and GH during pregnancy and early lactation. 
Materials and Methods 
Meishan gilts exhibiting two consecutive normal estrous cycles averaging 21± 1 d 
(mean ± SE) were used in this experiment. Six gilts were bred to Meishan boars on the first 
day of the second observed estrus. Eleven unmated gilts were hysterectomized via the mid-
ventral laparatomy (Anderson et al., 1961) on day 8, estrus was designated day 0. After a 24-
h fasting period animals were restrained by nasal snare on the day of surgery, and anesthesia 
was administered by ear vein injection of thiamylal sodium (0.8-1.Og; Surital, Parke-Davis, 
Detroit, MI). Animals were maintained under anesthesia by a closed circuit system of 
halothane (3-10%, Ayerst Laboratories, Rouses Point, NY.) and oxygen (400-1000 cc/min) 
for the rest of surgery. At the time of hysterectomy, the number of corpora lutea and the 
diameter of each were recorded. Four randomly selected corpora lutea were marked on each 
ovary with a loop of black silk suture for later identification. Reexamination of the state of 
the ovarian structures was performed at the end of the experiment through mid-ventral 
laparatomy. The experiment described here was reviewed and approved by the Iowa State 
University Laboratory Animal Care Advisory Committee. 
Experimental groups 
Two days before the start of the blood sample collection period, gihs were 
anesthetized by the ear vein injection of thiamylal sodium and maintained in a closed circuit 
system of halothane and oxygen. Cannulation (id, 1.27 mm; od, 2.29 mm; Tygon microbore 
tubing. Fisher Scientific, Pittsburgh, PA) of cranial vena cava was performed to allow 
repeated blood sampling. The catheter was tunneled under the skin and exteriorized at the 
junction of the scapula according to the procedure described by Ford and Maurer (1978). 
Hysterectomized gilts were confined to individual indoor pens in a controlled environment 
(18-220C) during the remainder of the experimental period. Mated gihs were housed in 
individual farrowing units (18-220C) where they remained with their off-spring during 
lactation. Blood samples were collected fi-om the cranial vena cava beginning on day 90 afl;er 
estrus or mating. Blood samples (10ml) were collected in disposable borosilicate culture 
tubes (16 X 100 mm) containing 0.2 ml of a solution of heparin sodium salt (100 lU/ml); 
NBCO Biochemicals, Cleveland, OH). Sequential blood samples were collected once daily 
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(0800 h) from days 90-109, twice daily (0800 h and 2000 h) from days 110-120, and every 20 
min within a 3-hour period beginning at 1200 h from days 112-116. Blood samples were 
immediately centrifiiged after collection (2000g, 4° C, 10 min). Plasma was stored at -20OC 
until relaxin, progesterone, PRL and GH were measured with RIA techniques. 
Radioimmunoassays 
RIA of relaxin in peripheral plasma 
Relaxin concentrations were quantified in duplicate in aliquots of 25-100/iZ plasma by a 
double antibody RIA using l^Sj.iabeled monotyrosylated porcine relaxin (Schwabe, 1983) 
prepared by Dr. C. Schwabe (Medical University of South Carolina, Charleston, SC) and R 6 
antibody from Dr. B.G. Steinetz (New York University Medical Center, Tuxedo, N.Y.) by 
procedures described previously (O'Byme and Steinetz, 1976; Felder et al., 1986). The assay 
sensitivity for peripheral plasma, defined as the quantity of unlabeled hormone that will change 
the distribution of radioactivity by an amount equal to the standard diviation of the 
experimental determination of bound/free hormone in the absence of unlabeled hormone was 
40 pg/ tube (Campfield, 1983). To determine the precision and the accuracy of this assay, 25, 
50, 100, 500, 1000, 1500, 2000, 3000, and 4000 pg purified porcine relaxin were added to 
quadruplicate aliquots of 100/j peripheral plasma from an ovariectomized gilts. These 
standard plasma samples were assayed, values from the plasma of ovariectomized animals 
were subtracted, and relaxin concentrations were averaged (± SE; 26 ± 2, 45 + 3, 66 ± 1, 
631 ± 1, 631 ± 6, 1290 ± 21, 1800 ± 30, 2280 ± 98, 2910 ± 91 and 4010 + 97 pg. 
respectively). Means for within-assay comparisons (n = 2 samples of relaxin in peripheral 
plasma from gilts on day 90 and 114 of pregnancy) were 0.71 ± 0.003 and 83 ± 3.0 ng/ml (± 
SE), with intraassay coefBcients of variation of 8.7% and 6.5%, respectively. Means for 
interassay comparisons (n = 7 assays) of relaxin in gilts on day 90 and 114 of pregnancy were 
0,76 ± 0.03 and 67 ± 4.7 ng/ml with interassay coefficient of variation of 10.1 and 14.6%, 
respectively. 
RIA of progesterone in peripheral plasma 
Plasma progesterone was extracted with a benzene-haxane mixture (1:2 vol/vol) using 
a modified version of the procedure described by Louis et al. (1973). One hundred microliters 
of plasma were extracted in duplicate. A third replicate (lOO/j ) serves as a recovery for 
procedural losses by the addition of 500 cpm [1,2,6,7-N-^H] progesterone (97.0 ci/m mol; 
New England Nuclear Corp, Boston, MA). Plasma extracts were assayed for progesterone by 
a modification of the RIA procedure described by Anderson et al. (1979) using the fiilly 
characterized antibody (GDN antiprogesterone -11-BSA 337) (Gibori et al., 1977; Klindt and 
Stone, 1984). The assay sensitivity of progesterone, as defined previously for relaxin was 50 
pg/tube (Campfield, 1983). To determine the precision and accuracy of this assay, known 
quantities of progesterone (100, 500, 1000, 2500, and 5000 pg) were added in aliquots (n = 
5) of 100^ peripheral plasma from an ovariectomized gilt. These standard plasma samples 
were extracted and assayed, values from the plasma of the ovariectomized animals were 
subtracted, concentrations of progesterone were averaged (± SE; 108 ± 3, 522 ± 10, 1000 + 
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15, 2500 + 42, 5000 ± 80 pg, respectively). The intraassay coefficient of the variation for the 
assay was 7.4% (11 determinations for one sample), and the interassay coefficient of variation 
was 14.8% (8 assay/sample). The mean recovery of progesterone after benzene-hexane 
extraction was 90%. 
RIA of PRL in peripheral plasma 
PRL concentrations in plasma were quantified by a double antibody homologous RIA, 
as described by Klindt and Stone (1984). Antisera were purchased fi^om Research Products 
International Corp. (Mt. Prospect, EL). The radioiodination preparation was USDA pPRL II 
(potency, 103 lU/mg) and USDA pPRL B1 (potency, 34 lU/mg) was used as a reference 
preparation. The radioiodinated pPRL was prepared by the chloramine-T method of 
Greenwood et al. (1963). Specificity was established by parallelism of various sera, plasma, 
and pituitary extracts with the reference by purified pLH, pFSH, and pGH. The sensitivity of 
the assay was 0.34 ± 0.15 ng/ml (mean ± SD, n = 8), as computed by the method of 
Duddleson et al. (1972). The intraassay coefficient of variation was 8.9 ± 6.8% (mean ± SD; 
two samples per assay; five to eight determinations), and the interassay coefficients of 
variation was 5.3 ± 3.8% (mean + SD), two samples; two assays). 
RIA of GH in peripheral plasma 
GH concentrations were determined in duplicate 200-/j aliquots of plasma by a double 
antibody homologous RIA (Klindt et al., 1983). The sensitivity of the assay was 230 ± 32 
pg/ml (mean ±SE; n = 4 assays). Inter-and intraassay coefficients of variation (mean ±SE) 
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were 24.4% and 9.5 ± 1.9% at mean concentration of 746 pg/ml (n = 4 assays) and 12.2% 
and 8.3 ± 0.2% at a mean concentration of 34 ng/ml (n = 4 assays), respectively. 
Statistical Analysis 
Experimental units in this experiment were the individual gilts, and they were assigned 
to treatments at random. Data were analyzed by split-plot analysis using a one-way analysis 
of variance, and a Student's t test for continuous variables was used for comparisons between 
treatment groups (Senedecor and Cochran, 1980; Spector et al., 1985). 
Results 
Relaxin concentration in pregnant and hysterectomized Chinese Meishan gilts 
Plasma relaxin concentrations were measured daily from day 99 to day 120 in both 
mated and hysterectomized Meishan gilts (Fig. 1). The day of parturition (day 114) in both 
groups was designated day 0 in Figs. 1, 2, 3, 4, and 5. Relaxin concentrations remained 
consistently greater (6 ± 1.0 ng/ml, mean ± SE) in hysterectomized gilts compared with 
pregnant gilts (2 ± 0.4 ng/ml) from day 99 to day 109 [equivalent to days -16 to -6 (mean ± 
SE), P< 0.05]. The relaxin concentrations confirm previous work with Yorkshire gihs 
(Anderson et al., 1983; Felder et al., 1986) where hysterectomized gilts had higher relaxin 
mean concentrations compared with pregnant animals at days 100-110. A gradual rise in 
relaxin concentrations began on day 111 in pregnant pigs and led to a steep rise (P < 0.01) on 
days 112-114 (equivalent to days -3 to 0 in Fig. 1). Relaxin peaked at 34 ± 4.2 ng/ml in 
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hysterectomized gilts compared with 66 ± 10.9 ng/ml in pregnant gilts (P < 0.05), the relaxin 
peaks occurred on day 114 in both groups. 
There was a sustained rise in relaxin levels over a 3-day period in pregnant gilts which resulted 
in the peak release that occurred on day 114 whereas 4 days of increase in relaxin levels 
preceded the relaxin peak in hysterectomized gilts (Fig. 1). By day 1 postpartum relaxin 
concentration decreased from a peak of 66 + 10.9 ng/ml to 1 ± 0.3 ng/ml and remained low 
until day 120. In hysterectomized gilts, relaxin levels declined sharply from a peak of 34 + 
4.2 ng/ml to 13 ± 3.2 ng/ml within 1 day but remained higher (P< 0.05) than in lactating pigs 
until day 120. 
Progesterone concentration in mated and hysterectomized Meishan gilts 
Peripheral plasma concentrations of progesterone in hysterectomized gilts were higher 
(P < 0.05) than in pregnant gilts (29 ± 3.3 and 18 + 1.9 ng/ml, respectively) from day 99 to 
day 109 (equivalent to days -16 to -6 in Fig. 2). Thereafter, progesterone decreased by half 
from day 109 to day 115 and remained at 16 ng/ml to day 120 in hysterectomized gilts. In 
contrast, progesterone concentration decreased sharply from 18 ± 1.9 ng/ml 6 days before 
parturition to basal levels (<0.05 ng/ml) after parturition and continued at basal levels until 
day 120. The decline in progesterone levels in hysterectomized pigs coincided with the 
marked decline observed before parturition in pregnant pigs, however the progesterone 
concentrations remained greater (P < 0.05) in hysterectomized gilts compared with pregnant 
animals (16 and < 0.05 ng/ml, respectively). 
Figure 1. Reiaxin concentrations in peripheral plasma of Meishan gilts during 
pregnancy and lactation (•) compared with those in umnated gilts 
hysterectomized (A) on days 6 to 8 after estrus. The day of parturition in 
pregnant animals and the day after peak hormone level in hysterectomized 
pigs is designated day 0. The number of gilts in each group is indicated in 
parenthesis. Values are mean ± SE. 
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Figure 2. Progesterone concentrations in peripheral plasma of Meishan gilts during 
pregnancy and lactation (•) compared with those in unmated gilts 
hysterectomized (A) on days 6 to 8 after estrus. The day of parturition in 
pregnant animals and the day subsequent to relaxin surge in hysterectomized 
animals is designated day 0. The number of gihs in each group is shown in 
parenthesis. Values are mean ± SE. 
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Relaxin secretion pattern during frequent bleeding 
Relaxin levels were determined in plasma of hysterectomized and pregnant gilts 
collected by frequent bleeding every 20 min from a 3-h period beginning at 1200h on day 112 
through day 116. Individual pig profiles of relaxin secretion during frequent bleeding revealed 
no evidence of consistent episodic relaxin release in both pregnant and hysterectomized 
animals (Figs. 3 and 4, respectively) in the study. However, there were relaxin concentration 
shifts within 20 min of frequent bleeding observed (Fig. 3). 
PRL and GH secretion in hysterectomized and pregnant Meishan gilts 
PRL concentration in peripheral plasma of hysterectomized gilts remained low (4 + 
0.8 ng/ml) throughout the period of the study whereas in pregnant gilts PRL levels increased 
steadily from 16 ± 0.8 ng/ml on day 99 to 39 ± 10 ng /ml at parturition (day 114) and 
remained at high concentration during lactation (Fig. 6). 
Growth hormone levels (Fig. 7) were similar in hysterectomized and pregnant gilts 
from day 99 to day 114, however GH concentrations was consistently higher (P < 0.05) in 
lactating compared with hysterectomized gilts (2.6 ± 0.6 vs 1.0 ± 0.3 ng/ml, respectively). 
Again no episodic GH release was observed in both pregnant and hysterectomized pigs (Figs. 
8 and 9, respectively). There were dramatic shifts in PRL and GH secretion patterns at 
parturition in pregnant gilts while secretion of these hormones remained unchanged in 
hysterectomized animals. 
Relaxin concentrations in peripheral plasma of pregnancy and lactation 
Meishan gilts bled every 20 min. within a 3-h period beginning at 1200 h from 
days 112 to 116. Four-digit numbers denote individual animals. 
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Figure 4. Relaxin concentrations in peripheral plasma of hysterectomized Meishan gilts 
bled every 20 min. within a 3-h period begiiming at 1200 h from days 112 to 
116. Four-digit numbers denote individual animals. 
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Growth hormone concentrations in peripheral plasma of pregnant and 
lactating Meishan gilts bled every 20 min. within a 3-h period beginning at 
1200 h from days 112 to 116. Four-digit numbers denote individual animals. 
GROWTH HORMONE IN PERIPHERAL PUSMA OF PREGNANT GILTS (ng/ml) 
Growth hormone concentrations in peripheral plasma of hysterectomized 
Meishan gilts bled every 20 min. within a 3-h period begiiming at 1200 h from 
days 112 to 116. Four-digit numbers denote individual animals. 
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Figure 7. Prolactin concentrations in peripheral plasma of Meishan gilts during 
pregnancy and lactation (•) compared with those in urmiated gilts 
hysterectomized (A) on days 6 to 8 after estrus. Day 0 is the day of 
parturition in pregnant animals and the day after peak relaxin release in 
hysterectomized pigs. The number of gilts in each group is indicated in 
parenthesis. Values are mean ± SE. 
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Figxire 8. Growth hormone concentrations in peripheral plasma of Meishan gilts dnring 
pregnancy and lactation (•) compared with those in unmated gilts 
hysterectomized (A) on days 6 to 8 after estrus. The parturition day in 
pregnant animals and the day after peak relaxin profiles in hysterectomized 
animals is designated day 0. The number of gilts in each group is indicated in 
parenthesis. Values are mean ± SE. 
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Discussion 
Relaxin is involved in the regulation of physiological and biological processes that 
occur during late pregnancy and parturition in mammalian species to prepare the reproductive 
tract for safe delivery (Anderson et al., 1987; Sherwood, 1994). The results of this study 
show that in hysterectomized pigs there is an inherent timed peak release of relaxin and a 
coincident decline in progesterone secretion that resembles the trends of these hormones in 
pregnant animals a few hours before delivery. This is in agreement with previous findings 
(Felder et al, 1986) where relaxin and progesterone profiles in hysterectomized and pregnant 
Yorkshire pigs had similar trends at comparable reproductive stages. The mechanism(s) 
responsible for the shifts in relaxin and progesterone secretion in pregnant gilts is not well 
understood. Evidence obtained fi"om studies with several species suggests that prostaglandin 
F2 a may be involved in the initiation of relaxin release. Furthermore, prostaglandin F2 a is 
known to cause luteolysis (King and Wathes, 1989). Infiision of prostaglandin F2 a on day 
110 of pregnancy in pigs (Sherwood et al., 1979) or intramuscular injection of prostaglandin 
F2a on day 112 (King and Wathes, 1989) induced parturition within 30 hours and initiated 
luteolysis and a surge release of relaxin in peripheral plasma. These events are similar to what 
occurs preceding parturition in normal pregnant pigs. 
The shift in relaxin and progesterone secretion is, however, different in 
hysterectomized gilts in that there is diminished secretory ability of corpora lutea without 
apparent structural luteal regression. The corpora lutea in hysterectomized gilts remained 
large (>450 mg) and also showed fine structural features indicative of some hormonal 
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secretion capacity. In contrast, luteal regression proceeded following parturition and 
continued through early lactation with relaxin and progesterone concentrations in peripheral 
plasma reaching undetectable levels. This study provides insight into the similarity in relaxin 
and progesterone secretion in Yorkshire gihs (Felder et al., 1986) and Chinese Meishan gilts 
during late pregnancy and early lactation. It seems likely that a common mechanism(s) exists 
in these breeds of pig which controls the initiation of processes that lead to parturition. The 
observation that the timing of the peak release of relaxin in hysterectomized and pregnant pigs 
in this study is almost identical to that seen in Yorkshire gilts (Felder et al., 1986) confirms the 
view that the prepartum shift in hormone secretion in hysterectomized and pregnant pigs may 
be regulated autonomously at the level of the ovary or the central nervous system (Felder et 
al., 1986). In concurrence with previous studies (Felder et al., 1986; Adair et al., 1989), 
plasma concentrations of progesterone were consistently greater in hysterectomized gilts 
compared with pregnant animals from day 99 to day 108. From day 109 to day 114 there was 
a substantial decrease in progesterone concentrations in hysterectomized pigs that surprisingly 
coincided with the decrease observed in pregnant animals between day 109 to 114 (Felder et 
al, 1986), however progesterone concentrations continued to be greater in hysterectomized 
pigs. This suggests a signal that triggers complete luteolysis in pregnant gilts and drastic 
reduction in luteal function in hysterectomized gilts. The difference in progesterone 
concentrations in hysterectomized and pregnant gilts at this stage may represent differences in 
steroid metabolism resulting in the delay of luteolysis in hysterectomized gilts. 
The regulation of PRL secretion is mediated by both PRL-releasing factors and PRL-
inhibiting factors (Ben-Jonathan et al., 1989). Dopamine is widely accepted as a principal 
PRL-inhibiting factor (Ben-Jonathan, 1985), while thyrotropin releasing hormone (Tashjian et 
al., 1978) and oxytocin (Samson et al., 1986) are also some of the prolactin-releasing factors. 
A variety of other substances have a stimulatory effects on prolactin secretion. 
Intracerebroventricular administration of relaxin in hysterectomized gilts on day 111 induced a 
marked increase in plasma prolactin concentration which suggests that relaxin has a central 
stimulating effect on PRL secretion (Li et al., 1993). This finding led to the proposition that 
possibly the periparturient relaxin surge causes the PRL surge before delivery (Li et al., 1993). 
In this study, relaxin and PRL followed similar secretory patterns in pregnant pigs with the 
relaxin prepartum surge occurring before a surge in PRL release. In hysterectomized animals, 
PRL concentrations remained consistently low throughout the duration of the experiment. 
This difference in PRL secretion between the pregnant and hysterectomized animals indicates 
that the periparturient PRL rise may be associated with the onset of lactation. This conclusion 
is consistent with Taveme et al. (1982), who showed that bromocriptine administered at the 
time of delivery could block lactation but had no effect on parturition. The involvement of 
PRL in lactogenesis in the pig is further supported by Vale and Wagner (1981) who observed 
an increase in PRL and estrogen levels which coincided with parturition and a decline in 
progesterone levels. In the present study, although no change in PRL secretion was observed 
in hysterectomized gilts, plasma PRL levels steadily increased in pregnant gilts. PRL is 
reported to have a luteotrophic role in the second half of pregnancy in the pig (Szafranska and 
Tilton, 1993). 
When hyperproiactinaemia was induced in pregnant pigs by administration of 
haloperidol (a D1 and D2 receptor antagonist), luteinizing hormone levels decreased but 
plasma progesterone concentration levels remained significantly higher than in control animals 
(Szafi'anska and Tilton, 1993). This finding is consistent with the observation by Li et al. 
(1989) that PRL has a luteotrophic function in aging corpora lutea in pigs, PRL administration 
prevented luteal regression after hypophysectomy. Despite the difference in PRL 
concentrations in hysterectomized and pregnant animals in this study, it is likely that the 
plasma PRL levels in hysterectomized gilts is sufficient for the support of luteal function. The 
observed substantial increase of in the PRL receptor concentration in the pig ovary which 
correlates with increasing gestational age further supports the luteotrophic function of PRL 
(Bramley and Menzies, 1987). Furthermore, it has been demonstrated that PRL can promote 
progesterone production by luteal cells fi-om pregnant pigs (Rajkumar et al, 1985). It is 
possible that PRL has a complex of functional roles during different physiological stages in the 
pig, the complete role of PRL is clearly not understood to date. 
The secretion of GH is regulated by two factors of hypothalamic origin (Frohman and 
Jansson, 1986), the grow^th hormone-releasing hormone (GHRH) which stimulates secretion 
and somatostatin (SRIF) that inhibits secretion. The role of GH in late pregnancy and early 
parturition in several species has been identified as supportive of processes that facilitate milk 
synthesis by the mammary gland (McDowell et al., 1988; Sandles et al., 1988; Jahn et al.. 
1993). In this study, GH concentrations were similar in both hysterectomized and pregnant 
gihs from day 99 until parturition. However, after delivery GH levels were consistently 
greater in lactating gilts compared with hysterectomized animals. This finding suggests that 
GH may be involved in lactation in the pig. The possible role of GH in lactation is confirmed 
by Farmer et al. (1992) who concluded that GHRH given during pregnancy had no effect on 
sow and litter performance, but PRL utilization and litter performance improved when GHRH 
was given during lactation. Increased plasma GH concentrations have been observed after a 
few days before parturition in the rat (Jahn et al., 1991), and this was found to be associated 
with an increase in PRL receptors in the mammary gland. This association between GH and 
PRL activity is further evidence that GH may be involved in lactation. Biochemical changes 
associated with milk synthesis were observed when GH was given to lactating ewes over a 5 
day period (McDowell et al., 1988). The increase in GH secretion in lactating pigs in this 
experiment may be caused by the demand for nutrient availability in the mammary gland to 
sustain lactation. It is not known, however, what triggers the release of GH during lactation 
in the pig, and the mechanism(s) by which this hormone elicits its function is yet to be 
determined. 
In summary, this study demonstrates that PRL has a physiological role in the onset and 
maintenance of lactation in the pig. Furthermore, GH appears to have a supportive role 
during the initiation and maintenance of lactation in the sow. The secretion of both PRL and 
GH at or near parturition in pregnant gilts was different from hysterectomized animals. 
Ovarian secretion of progesterone and relaxin is precisely controlled by aging corpora lutea in 
54 
both pregnant and hysterectomized Meishan gilts. This is consistent with the finding by Felder 
et al. (1986) who hypothesized that the shifts in ovarian relaxin and progesterone secretion 
prepartum is regulated at the level of the ovary or fi-om the CNS and pituitary gland in both 
hysterectomized and pregnant Yorkshire gilts. 
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ANTIPORCINE RELAXIN (ANTIpRLX540) TREATMENT REDUCES THE 
CONCENTRATION OF UNBOUND OR FREE RELAXIN AND DISRUPTS 
DELIVERY IN LATE PREGNANT PIGS 
A paper to be submitted to Animal Reproduction Science 
B. J. Dlamini, J. Klindt and L. L. Anderson 
Abstract 
Relaxin antibody against porcine relaxin (antipRLX540) was produced in sheep and 
used to determine whether it would impair parturition in late pregnant pigs. The effect of 
antipRLX540 on relaxin concentrations was also examined from late pregnancy to early 
lactation (days 103-120). Twenty Yorkshire gilts with normal estrous cycles were bred on the 
second observed estrus and fitted with an indwelling jugular cannula and an intraperitoneal 
cannula on day 100 of pregnancy. Beginning on day 103 to day 120, daily blood samples (10 
ml) were collected for RIA of relaxin, progesterone and prolactin. Gihs were infused at 6-h 
intervals with antipRLX540 (n = 10) or PBS (n = 10) beginning on day 103 until parturition. 
Duration of delivery from first to last piglet was greatly delayed in antipRLX540 gilts (240 
min) compared with PBS controls (117 min) (P < 0.005). The average number of stillboms 
was greater in antipRLX540- than in PBS-treated controls (1.7 vs 1.0; P < 0.05). 
The concentration of unbound or free relaxin was decreased (P < 0.01) compared with 
unextracted plasma of antipRLX540-treated gilts on days 104 to 113. Relaxin concentration 
in peripheral plasma was lower in antipRLX540-treated gilts from day 105 to day 110, but on 
day 113 the antipRLX540-treated group had a higher relaxin peak compared with PBS-
treated animals. Plasma progesterone concentrations were similar in antipRLX540- and PBS-
treated gilts throughout the period of the study. 
Plasma prolactin concentration tended to be higher in the antipRLX540 group, and 
this difference became significant on days 1 to 3 after parturition. The study indicates that 
antiporcine relaxin antiserum greatly decreases circulating plasma concentrations of unbound 
or free relaxin during the last 10 days of pregnancy in Yorkshire gihs. The antipRLX540 
markedly increases the duration of delivery of piglets and increases the average number of 
stillbirths in this litter-bearing species compared with PBS-treated controls. This study 
provides strong evidence that increasing circulating concentrations of relaxin during late 
pregnancy are crucial for unimpaired parturition in the pig. 
Introduction 
Relaxin and progesterone are produced by corpora lutea of pigs during pregnancy and 
after hysterectomy (Belt at al., 1971; Anderson et al, 1983). During a normal pregnancy of 
about 114 days, the concentrations of circulating progesterone peak by day 8 and remain high 
until they decrease just before parturition (Adair et al., 1989). Relaxin accumulates in luteal 
tissue and increases gradually during pregnancy, and is released into the blood in peak 
quantities just before parturition (Anderson et al., 1973; Sherwood et al., 1975). Relaxin 
remodels collagen (Eldridge-White et al., 1989), stimulates uterine growth (Vasilenko and 
Mead, 1987), and inhibits contractility of the uterus (Downing and Hollingsworth, 1993). In 
contrast to its effects on the uterus, relaxin stimulates the contractile force of atrial muscle of 
the heart (Ward et al, 1992). One of the primary target organs for the biological actions of 
relaxin is the uterine cervix. The remarkable effects of relaxin on this organ include inducing 
growth and remodeling of connective tissue and cervical cells to accommodate pregnancy and 
parturition (Kertiles and Anderson, 1979; O'Day et al., 1989). The related physiological and 
clinical observations include softening, ripening and dilating the cervix and facilitating delivery 
of the young (O'Day et al., 1989, 91; Winn et al., 1993). From studies on relaxin in different 
mammalian species (Sherwood and O'Byme, 1974; BOllesbach and Schwabe, 1985; Bryant-
Greenwood and Schwabe, 1994), pigs are known to produce comparatively large quantities of 
relaxin during pregnancy. This may relate directly to the high incidence of uneventful and 
easy delivery of newborns by gilts and sows, compared with the relatively high incidence of 
difficult birth (dystocia) frequently seen in first-calf heifers (Laster et al., 1973). Relaxin 
treatment during late pregnancy in cattle causes cervical dilation, facilitates calf delivery, and 
reduces the incidence of dystocia (Musah et al., 1986; Bagna et al., 1991). Guico-Lamm and 
Sherwood (1988) passively immunized pregnant rats on day 12-22 with MCAl and observed 
that MCAl-treated rats had prolonged duration of straining with reduced survival rate of pups 
compared with PBS-treated rats. This study was designed to 1) determine whether antiserum 
to porcine relaxin produced in sheep would affect parturition in late pregnant pigs, 2) assess 
the duration of delivery from first to last piglet, average number of stillborn, and newborn 
survival rates, 3) compare concentrations of circulating progesterone, relaxin and PRL in 
antipRLX540-and PBS-treated gilts, and 4) measure unbound or free relaxin plasma of gilts 
by extraction with polyethylene glycol and precipitation with triton X-100 of blood from 
antipRLX540-and PBS-treated gilts. 
Materials and Methods 
Twenty Yorkshire gilts with normal estrous cycles were bred (day = 0) at second 
observed estrus to fertile Yorkshire boars and confirmed pregnant. The expected length of 
gestation in this group of animals was 114 days. On day 100 each gilt was anesthetized by ear 
vein injection of thiamylal sodium and maintained on a close circuit system of halothane and 
oxygen. Gilts were then fitted with an indwelling jugular cannula (id 1.27 mm; od, 2.29 mm; 
Tygon microbore tubing, Fisher Scientific, Pittsburgh, PA) and an indwelling intraperitoneal 
(in the right lower flank) cannula of the same size and composition. Beginning on day 103 to 
day 120, twice daily blood samples (10 ml) were collected at 12-h intervals from each gilt for 
RIA of progesterone, relaxin, and PRL. Using antiporcine relaxin antibody (antipRLX540) 
produced in sheep with high antibody titer (1:950,000) or PBS (n =10 for each group), gilts 
were infiised at 6-h intervals beginning day 103 (12 days before expected parturition) to 
parturition. Gilts were observed for exact time of parturition to establish the interval between 
delivery of individual piglets, total delivery time (from first to last piglet), incidence of 
stillboms and neonatal survival. The animal experimentation described here was reviewed and 
approved by the Iowa State University Laboratory Animal Care Advisory Committee. 
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RlAs of relaxin, progesterone and prolactin in peripheral plasma 
Relaxin was quantified in duplicate 200fU aliquots of plasma by using a homologous 
double-antibody RIA for porcine relaxin as described previously (Felder et al., 1986; O'Byrne 
and Steinetz, 1986). The sensitivity of the assay was 40 pg/tube. The inter- and intraassay 
coefficients of variation were 12.4% n = 3 assay/sample and 6.2% (n = 5 samples); nonspecific 
binding was 2.8%. 
Extraction and assay of unbound or free plasma relaxin in peripheral plasma 
1. For each sample containing antibodies to RLX, 200 ml of plasma and 400 ml of 
polyethylene glycol (PEG [average molecular weight 6,000 to 7,500, J. T. Baker, Phillipsburg, 
NJ]; 15% w/v, dissolved in PBS-1% BSA) are added to culture tubes (12 x 75 mm), vortexed, 
incubated for 15 min at 4°C, and centrifuged at 1,150 x g for 10 min in a refiigerated (4°C) 
centrifijge. The supernatant was decanted and saved. [Supernatant I] 
2. The precipitate was vortexed with 300 ml of Triton X-100 
(octylphenoxyprolyethoxyethanol, Sigma Chemical Co., St. Louis, MO; 0.40% v/v, diluted in 
PBS-1% BSA) until solubilized and then incubated for 10 min at 4°C. 400 ml of PEG (25% 
w/v dissolved in PBS) are added and the tubes vortexed, incubated for 15 min at 4°C and 
centrifiiged (1,150 x g at 4°C). Again, the supernatant was decanted and saved. [Supernatant 
II] 
3. The precipitate was resolubilized in 0.40% Triton X-100 and incubated for 15 min at 4°C; 
400 ml of 25% PEG are again added and the tubes are vortexed, incubated for 15 min at 4°C, 
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and centrifuged (1,150 xg at 4°C). The supernatant was decanted and saved, and the 
precipitate was discarded. [Supernatant III] 
4. Supematants I, II, and III are pooled and then vortexed. A 500-ml aliquot (representing 
50 ml of plasma) was used for the RLX radioimmunoassay. 
5. To determine whether antipRLX540 antibodies have a neutralizing or enhancing effect, 25-
, 50-, and 100-ml aliquots of a plasma pool from PBS control gilts are incubated 24 h at 4°C 
with added antipRLX540 (25 ml). This mixture was extracted as described above, and 
assayed for RLX. 
Progesterone was extracted with benzene-hexane mixture (1:2 vol/vol) using a 
modified version of the procedure described by Louis et al. (1973). One hundred microliters 
of plasma were extracted in duplicate. Plasma extracts were assayed for progesterone by a 
modification of RIA procedure described by Anderson et al. (1979) using the fiilly 
characterized antibody (GDN antiprogesterone-ll-BSA337) (Niswender, 1973; Gibori et al., 
1977). Recovery after extraction with benzene was 89%, and the minimal detectable 
concentration of progesterone was 50 pg/tube. The inter- and intraassay coefficient of 
variation were 11.3% (n = 5 assays/sample) and 8.5% (n = 6 samples), respectively; 
nonspecific binding was 3.1%. 
PRL concentration in plasma was determined by double antibody homologous RIA, as 
described previously by Li et al. (1989). The radioiodination preparation was pPRL II 
(potency, 103 lU/mg), and USDA pPRL B1 (potency, 34 lU/mg) was used as the reference 
preparation. The sensitivity of the assay was 0.7 ± 0.25 ng/mg (mean± SD; n = 5), and the 
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inter-and intraassay coefficients of variation were 14 ± 3.7% (meani SD; 2 samples; 5 
assays) and 7.4 ± 5.5% (mean± SD; 2 samples per assay; 2-4 determinations). 
Statistical analysis 
Experimental units were the individual pigs, which were assigned to treatments at 
random. Data were analyzed by one way analysis of variance for samples collected each day 
during hormone or vehicle infusion. Student's t test for continuous variables was used for 
comparisons between treatment groups (Snedecor and Cochran, 1980). 
Results 
Plasma concentration of relaxin, progesterone, and prolactin in Yorkshire gilts treated 
with antipRLX540 or PBS during late pregnancy 
Plasma progesterone concentrations (Fig. 1) were similar in antipRLX540- and PBS-
treated gilts from day 103 to day 112 (equivalent to day-11 to -2), (10 ± 1.5 and 10±2.5 
ng/ml, mean ± SE, respectively). After day 112, progesterone levels markedly decreased in 
both antipRLX540- and PBS-treated animals and remained at basal levels (<0.5 ng/ml) after 
parturition. 
Relaxin concentration in peripheral plasma (Fig. 2) was lower in antipRLX540-treated 
gilts from day 105 to day 110 (equivalent to day -9 to -4), however on day 113 the 
antipRLX540-treated group had a higher relaxin peak compared with PBS-treated animals 
(58 ±2.5 and 43 ± 1.7 ng/ml, P < 0.05). The concentration of unbound or free relaxin was 
decreased (P < 0.01) on days 106 to 110 and (P < 0.05) on days 104, 111 and 113 (Table 1 
and Fig. 3) compared with unextracted plasma of antipRLX540-treated gilts on day 104 to 
113 (from 10 days to 1 day before parturition), then remained similar throughout the study 
(Fig. 3). In PBS-treated gilts relaxin concentration in unextracted plasma was similar to that 
of extracted plasma throughout the period of the study (Table 1). 
Plasma PRL concentrations (Fig. 4) were low (10+ 1.6 ng/ml) in antipRLX540- and 
PBS-treated (12± 1.7 ng/ml) animals from day 103 to day 109 (equivalent to day -10 to -5). 
Thereafter PRL increased abruptly from day 109 to peak of 62 ± 5.7 ng/ml on day 113 
(equivalent to day -1) in antipRLX540 and 49 ± 11 ng/ml on day 114 (equivalent to day 0) in 
PBS-treated gilts. Beginning on day 1 to day 3 after parturition, PRL concentration in plasma 
was greater (P < 0.05) in antipRLX540-treated gilts compared with PBS-treated controls. 
PRL concentration from day 3 to day 120 were similar in both experimental groups. 
Delivery of Yorkshire gilts treated with antipRLX540 or PBS 
Data on parturition of Yorkshire gilts treated with antipRl.X540 or PBS are shown in 
Fig. 2. The duration of delivery (min) was greatly prolonged in antipRLX540-treated gilts 
compared with PBS-treated controls (214 vs 117; P < 0.05). The time of delivery from 
previous piglets (min) was also greater in antipRLX540-than PBS-treated gilts (P < 0.05). 
Gilts treated with antipRLX540 experienced prolonged durations of straining and the average 
number of stillboms was greater in this group than in PBS-treated gilts (1.7 vs 1.0; P < 0.05). 
The neonatal survival rate was significantly higher in PBS-treated compared with 
antipRLX540-treated gilts. 
Table 1. Relaxin concentration of unbound or free relaxin in peripheral plasma of Yorkshire gilts given antiporcine relaxin 
(antipRLX540) or phosphate buffer saline (PBS) during late pregnancy 
Relaxin in peripheral plasma, ng/ml 
PBS(n = 6) AntipRLX540 (n = 10) 
Days from 
parturition Unextracted plasma Extracted plasma Unextracted plasma Extracted plasma 
-10 2.7 ± 0.73 1.8 ±0.83 1.3 ±0.33 0.4 ± 0.25* 
-8 3.5 ±0.84 1.3 ±0.30 2.5 ±0.56 0.5 ± 0.29" 
-6 3.5 ±0.88 3.3 ±1.11 2.8 ±0.67 0.8 ± 0.42" 
-4 7.9±1.19 5.0 ±1.28 7.5 ±0.89 3.2 ±0.32" 
-2 19.3 ±2.13 17.3 ±3.25 21.0 ±3.98 14.7 ±3.28* 
-1 41.6 ±6.22 41.5 ±6.61 57.6 ±6.64 39.7 ±4.88* 
0 
4 
7.2 ±3.22 5.5 ±2.19 4.4 ± 1.05 2.9 ±0.88 
0.2 ±0.01 0.0 ±0.00 0.3 ±0.01 0.2 ± 0.24 
* P < 0.05 compared with unextracted plasma within treatment group. 
** p < 0.01 compared with unexpected plasma within treatment group. 
Figure 1. Description of experimental groups showing bleeding frequency for 
determination of relaxin, progesterone, and prolactin in antiporcine relaxin 
antiserum and phosphate buffer saline treated gilts. Also shown is day of 
continuous observation for delivery of piglets. 
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Figure 2. Effect of antiporcine relaxin antiserum and phosphate buffer saline on the 
interval for the delivery of each piglet within the litter. The duration of 
delivery was increased (P <0.01) in antipRLX540 treated gihs compared with 
PBS treated controls. Values are mean ± SE. 
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Figure 4. Effect of antiporcine relaxin antiserum and phosphate buffer saline on relaxin 
concentration in peripheral plasma during late pregnancy, parturition, and 
early lactation. Values are mean ± SE. 
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Figure 5. Concentration of unbound or free relaxin in peripheral plasma of Yorkshire 
gilts (n = 10) given antiporcine relaxin antiserum in extracted plasma (•) and 
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Values are mean ± SE. 
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Relaxin is a peptide hormone that is found in high concentration during late pregnancy 
in the pig; in most mammals, it has biological actions on pelvic and cervical connective tissue 
as well as uterine smooth muscles (Hall et al., 1990; Winn et al., 1992). These actions include 
growth-promoting effects, extensibility and increase in lumen diameter of these organs. In the 
pig, relaxin deficiency at parturition results in prolonged delivery time with high incidence of 
stillbirths (Kertiles and Anderson, 1979; Nara et al, 1982). In this experiment, intraperitoneal 
administration of antipRLX540 in late pregnant pigs impaired parturition suggesting a 
physiological requirement for endogenous relaxin at term for normal delivery of the newborn 
(Felder et al., 1986). The time of delivery fi-om previous piglet (min) and the duration of 
delivery were longer in antipRLX540-compared with PBS-treated gilts. The observed delay 
in the duration of delivery of piglets in this study may be attributable to lack of cervical 
remodeling in antipRLX540-treated gilts compared with PBS-treated controls. Eldridge-
White et al. (1989) demonstrated that relaxin promotes growth and distensibility of the cervix 
during late pregnancy in the pig, and that estrogen enhances the effects of relaxin that occur 
during this period. It appears that intraperitoneal infusion of antipRLX540 immunized against 
endogenous relaxin and considerably reduced the extent of cervical tissue modifications that 
occur during late pregnancy. The limited cervical physiological changes experienced by 
antipRLX540-treated pigs resulted in prolonged durations of straining and increased time of 
delivery in this group compared with diluent-treated animals. In the rat, passive neutralization 
of endogenous relaxin in late pregnancy has been shown to reduce cervical growth and 
extensibility (Hwang and Sherwood, 1988). The antipRLX540 infused group had a greater 
incidence of stillbirths and decreased survival rates of newborns, whereas PBS-infused gilts 
had significantly less cases of stillbirths and higher neonatal survival rates. Nara et al. (1982) 
reported that relaxin is required for the occurrence of a short duration of delivery of piglets 
and high survival rates at parturition. The absence of relaxin in peripheral plasma after 
ovariectomy of late pregnant pigs was associated with prolonged delivery and a marked 
increase of stillbirths (Nara et al., 1982). In the present study, neutralization of endogenous 
relaxin caused an increase in the number of stillbirths and a decrease in the survival rates of 
piglets compared with data of these parameters from PBS-treated pigs. The higher number of 
stillbirths and low incidence of live births in antipRLX540-treated pigs may be due to, at least 
in part, the increased duration of straining time in the unexpanded reproductive tract. 
Furthermore, since relaxin has been shown to have an influence on the onset of lactation in the 
pig (Nara et al., 1982), the decreased piglet survival rates shortly after delivery in 
antipRLX540-treated gilts were probably not due to lack of milk production by the mammary 
gland. Physically weak piglets after delayed delivery period could have contributed to 
neonatal losses because some piglets from antipRLX540-treated appeared to lack energy to 
immediately stand up and suckle shortly after delivery. It is however a little surprising that 
high circulating relaxin concentrations have been also associated with delayed delivery periods 
in the pig (Wathes et al., 1989). In attempting to explain this unexpected relationship between 
plasma relaxin concentrations and time taken to deliver piglets, Wathes et al. (1989) 
implicated the inhibitory effects of relaxin on both the myometrium and oxytocin release from 
the posterior pituitary. They suggested that it is only when relaxin concentration begin to 
decline that the myometrium inhibition is removed so that uterine contractility may occur. In 
cattle, exogenous relaxin treatment during late pregnancy promotes cervical distensibility, 
facilitates calf delivery, and reduces the incidence of dystocia (Bagna et al., 1991). Guico-
Lamm and Sherwood, (1988) demonstrated in the rat that in the second half of pregnancy 
passive immunization against endogenous relaxin causes delayed litter delivery, increased time 
of straining, reduced litter survival rates, and increased cases of retained fetuses and placentas. 
If antipRLX540 infusion exerts a similar effect in the pregnant gilt as MCAl in the pregnant 
rat, the difference in parturition problems observed in the present study between the 
antipRLX540-treated pigs and PBS-treated control is likely due to lack of endogenous 
relaxin. 
The expected increase in relaxin secretion that occurs on day 113 (Felder et al., 1986) 
was observed in both antipRLX540-treated and PBS-treated controls. Despite lower relaxin 
concentrations in peripheral plasma in antipRLX540-treated gihs from day 105 to day 110 
compared with PBS-treated animals, the relaxin peak release on day 113 was higher in 
antipRLX540-treated gilts. The peak relaxin release may be crucial for the relaxin-dependent 
changes that occur near parturition and may also have important physiological role in inducing 
PRL release in preparation for the onset of lactation. Relaxin administration into the brain 
induces a marked increase in PRL plasma concentration in hysterectomized gilts on day 111 
and 113 (Li et al., 1993), Rats treated with MCAl in the second half of pregnancy had less 
developed nipples and mammary glands and were less able to support pups during a 5-day 
foster period than control rats (Hwang et al., 1991). These authors concluded that the 
biological actions of relaxin on mammary development during late pregnancy are critical for 
the welfare of the piglet during lactation. Antiporcine relaxin in this study decreased 
circulating plasma concentration of unbound or free relaxin during the last 10 days of 
pregnancy in these Yorkshire gilts, it is likely that the farrowing problems observed in this 
group is associated with this decline in free relaxin since PBS-treated controls had markedly 
fewer parturition problems. The present data show that in PBS- and antipRLX540-treated 
pigs there was no difference in plasma progesterone concentration throughout the study. 
However PRL concentration in plasma was greater from day 1 to day 3 after parturition in 
antipRLX540-treated gilts compared with PBS-treated pigs. The significance of the temporal 
elevation in plasma PRL concentration in antipRLX540-treated gilts at the onset of lactation 
in this study is not clear. 
In summary, antipRLX540 markedly prolonged the duration of delivery of piglets, 
increased the average number of stillboms, and reduced the number of live piglets after 
delivery in this litter-bearing species compared to PBS-treated controls. This study provides 
strong evidence that increasing circulating concentrations of relaxin during late pregnancy are 
crucial for unimpaired normal parturition in the pig. 
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MIFEPRISTONE (RU 486) INDUCES PARTURITION IN PRIMIPAROUS BEEF 
HEIFERS WITHOUT THE DETRIMENTAL EFFECT OF DYSTOCIA 
A paper submitted to the Journal of Animal Science 
B. J. Dlamini, Y. Li and L. L. Anderson 
Abstract 
Mifepristone (RU 486) is a synthetic steroid having antagonistic properties to 
progesterone. Li et al. (1991b) demonstrated that administration of RU 486 alone or in 
combination with relaxin in late pregnant multiparous beef cattle induces parturition without 
detrimental reproductive problems. In this study, primiparous cross-bred beef heifers were 
bred by artificial insemination and on day 268 (expected parturition = 283) these heifers were 
fitted with an indwelling jugular cannula for sequential blood sampling fi-om days 270 to 278. 
Heifers were assigned at random to three groups (n = 7) on day 277: group 1 received RU 
486 (in ethanol at 2 mg/kg BW, im) at 0800 h on days 277 and 278; group 2 received 3000 U 
of purified porcine relaxin ,sc, at 0800 h on day 278 in addition to RU 486 treatment; group 3 
received diluent (ethanol, im and PBS, sc) injections on day 277 and 278 and served as 
controls. In animals treated with RU 486, parturition occurred 43 h after treatment. The 
interval between treatment and parturition in cows given the same RU 486 treatment plus 
relaxin (group 2) was 52 h. In contrast, diluent-treated control cows had the longest 
treatment to parturition interval of 182 h (P < 0.01). Hormone-treated heifers had lower calf 
birth weights (29 and 27 kg in groups 1 and 2, respectively) compared with 32 kg in diluent 
controls (P < 0.025), however all calves were vigorous at birth. Heifers in groups 1 and 2 
experienced less incidence of dytocia (lof 7 in group 1, and 2 of 7 in group 2) compared with 
diluent treated controls (4 of 7). However, placenta retention longer than 24 h was 2 of 7 in 
group 1, 6 of 7 in group 2 compared with 0 of 7 in control heifers. Plasma progesterone 
levels were similar (8.2 ng/ml) during the pretreatment period in all the groups, but began to 
decline in hormone-treated heifers by 1200 h on day 278. Progesterone concentrations 
decreased further and reached basal levels on day 279, the day of calving, in hormone-treated 
animals. Progesterone levels were maintained at about 7 ng/ml until day 282 (2 days before 
parturition) thereafter progesterone levels began to decrease and reached basal levels after 
parturition (P < 0.01). These results show that administration of RU 486 alone or in 
combination with relaxin precisely controls the time of parturition in first-calf heifers. 
Hormone-treated heifers had smaller yet vigorous calves and hormone treatment reduced the 
incidence of dystocia compared with diluent-treated animals. However, the incidence of 
retained placenta beyond 24 h occurred in hormone-treated animals whereas, diluent-treated 
animals experienced no prolonged retained placenta. 
Introduction 
Mifepristone (RU 486) is a synthetic steroid that possesses potent antagonistic 
properties to progesterone (Baulieu, 1985). It binds to the progesterone receptor (PR) with 
higher affinity than that of progesterone and prevents progesterone action (Baulieu, 1989). 
The ability of RU 486 to interact with PR has been widely used in the treatment of steroid-
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hormone related diseases (Kettel et al, 1991) and also in the investigation of molecular 
mechanisms involved in steroid hormone action (Mao et al., 1992). In general steroid 
hormones, particularly progesterone, are important for the establishment of a conducive 
uterine environment for implantation of the blastocyst and maintenance of pregnancy. 
Antagonizing this progesterone fiinction with RU 486 treatment prevents implantation and 
causes abortion in early pregnant women (Baulieu, 1989) and rats (Philibert et al., 1985). The 
mechanism by which RU 486 exerts its abortifacient action is still not quite understood. It is, 
however, believed that it stabilizes the binding of HSP-90 to the PR and maintains the inactive 
heterooligomeric 8s-form of the steroid receptor. This action prevents the DNA binding 
domain of the steroid receptor from interacting with hormone regulatory elements (HRE) of 
the DNA (Baulieu, 1989). RU 486 induced parturition in beef cows without the detrimental 
effects of dystocia, retention of placenta, and delayed postpartum fertility (Li et al., 1991b). 
The objective of this study was: 1) to examine the effects of RU 486, when applied alone or in 
combination with relaxin on the induction of parturition in late pregnant beef heifers, and 2) to 
determine the incidence of dystocia, expulsion of placenta and calf survival in hormone-treated 
cattle compared with placebo-treated controls. The incidence of dystocia is common in 
primiparous heifers (Laster et al., 1973), therefore hormonal control of time of delivery would 
improve calf survival without delay in postpartum cyclicity. 
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Materials and Methods 
Animals 
Twelve crossbred heifers, 2 years old, and weighing 360 ± 10 kg (mean ± SE) were 
bred by artificial insemination November 7 to 9, 1990 at Chariton-McNay Cattle Research 
Center. On day 265 of pregnancy (normal expected term is 283 days in this herd), the heifers 
were transferred to the Animal Reproduction Laboratory and acclimated in confinement pens 
for hormone treatments and calving. The heifers were then fitted with an indwelling jugular 
cannula (tygon microbore tubing; id, 1.27 mm; od, 2.29 mm; Fisher Scientific Pittsburgh, PA) 
for sequential blood sampling from days 270 to 278. The experiment described in this paper 
was reviewed and approved by the Iowa State University Laboratory Animal Care Advisory 
Committee. 
Experimental groups 
A study by Li et al. (1991b) had determined that RU 486 given at 2 mg/kg BW 
induced calving in beef cattle within 60 h. On day 277, the animals were randomly assigned to 
three groups (n = 7 each); group 1(RU 486) received RU 486 (in ethanol) at 2 mg/kg BW, 
im, once a day at 0800 h on day 277 and 278; group 2 (RU 486 plus relaxin) received 3000 U 
of purified porcine relaxin (in PBS), sc, at 0800 h on day 278 in addition to RU 486 treatment 
given to group 1; and group 3 (diluent) received diluent (ethanol, im and PBS, sc) injections 
on day 277 and 278 and served as controls. Relaxin used in this study was extracted from 
ovaries of pregnant pigs and purified according to the procedures described by BUllesbach and 
Schwabe (1985). Mifepristone (RU 486), lip-(4-dimethyl-amino-phenyl)- 17p-hydroxy-17a-
(l-propynyl)-estra-4, 9-dien-3-one) was a gift from Dr. D. Philibert, Roussel-UCLAF, Paris. 
Jugular blood (10 ml samples) was collected daily from day 270 through parturition and early 
postpartum for radioimmunoassay of progesterone concentration in plasma. The heifers were 
monitored continuously to precisely determine the time of parturition, dystocia, calve birth 
weight and placenta delivery. On the day of delivery calf head circumference (distance in cm 
from middle of frontal bones around the neck) and calf chest circumference (distance in cm 
around the body taken just behind the shoulders) were measured. Blood samples were 
collected in disposable borosilicate culture tubes (16 x 100 mm) containing 0.2 ml heparin 
sodium sah solution (100 lU/ml; NBCO Biochemicals, Cleveland, OH). After collection of 
blood samples, tubes were immediately centrifiiged (2000 x g) for 10 min and plasma was 
decanted and stored at - 20 °C until assayed for progesterone content. 
RIA of progesterone in peripheral plasma 
Progesterone was determined in duplicate 200-^1 aliquots of plasma by RIA 
procedures described by Musah et al. (1987) using fully characterized antibody (GDN-337) 
(Gibori et al., 1977). Recovery after extraction with benzene-hexane was 86 + 0.9%, and the 
minimal detectable concentration of progesterone was 0.25 ng/ml. The inter- and intraassay 
coefficients of variation were 17.3% (n = 9) and 8.2% (n = 9); nonspecific binding was 3.1%. 
Statistical analysis 
Experimental units were the individual cows and they were randomly assigned to 
treatments. Data were analyzed by a split plot analysis of variance, and Student's t test for 
continuous variables was used for comparisons between treatment groups (Snedecor and 
Cochran, 1980; Spector et al., 1985). 
Results 
Birth distribution observed in the study is given in Table 1. In animals treated with RU 
486 at 24-h intervals on day 277 and 278 parturition occurred 43 h after the first treatment 
(group I). The interval between treatment and parturition in cows given the same RU 486 
treatment plus relaxin was 52 h (group 2). In contrast, diluent treated control cows (group 3) 
had longest mean duration from first treatment for delivery, 182 h. Hormone treatment 
markedly shortened pregnancy duration in groups 1 and 2 compared with control group 3 
(Table 1). Calf data at the time of parturition are shovm in Table 2. Hormone-treated heifers 
had calf birth weights that were lower than those of the control group. Likewise, head and 
chest circumferences of calves from hormone treated animals were less than those of control 
animals. Table 3 shows that in group 1 (RU 486 alone) only 1 of 7 dams experienced dystocia 
that required manual assistance, and 2 of 7 heifers in group 2 (RU 486 plus Relaxin) 
compared with 4 of 7 heifers in the control group (diluent). The incidence of expulsion of 
placenta longer than 24 h postpartum was 2 of 7 in group 1, and 6 of 7 in group 2 compared 
with 0 of 7 in the control group (Table 3). Calves from hormone-treated groups and those 
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from the control group were vigorous at birth, and maternal behavior and lactation of the 
heifers were normal. 
The plasma profile of progesterone on days 270 to 276 (pretreatment period) 
averaged 8.2 ng/ml for all animals (Table 4). In the RU 486 group, intensive sampling 
revealed that RU 486 caused a significant decline in progesterone plasma concentration by 
1200 h on day 278. Plasma progesterone decreased further by 2400 h that same day and 
reached basal levels on day 279, the day of parturition (Table 1). RU 486 combined with 
relaxin increased the interval from treatment to parturition by 9 h, however the decrease in 
progesterone secretion was similar to that of cows given only RU 486 (Table 4). In contrast, 
progesterone was maintained at about 7 ng/ml in the diluent-treated controls during this 
period, and it did not decrease to basal levels until 2 days after parturition on day 286. 
Table 1. Antiprogesterone, RU 486, alone and combined with relaxin on facilitation of 
parturition in beef heifers 
Heifer Pregnancy First treatment 
duration to calving 
(n) Body wt (kg) (days) (h) 
RU 486 7 358 ± 7 279 ± 0.3 43 ± l" 
RU 486 + relaxin 7 354 ± 10 279 ± 0.2** 52 ± 6** 
Diluent 7 379 ± 18 284 ± 1.5 182 ± 38 
**P < 0.01 compared with diluent-treated controls; 
values are mean ± SE. 
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Table 2. Antiprogesterone, RU 486, alone and combined with relaxin on facilitation of 
parturition in beef heifers 
Calf 
Birth Circumference (cm) 
wt (kg) Head Chest 
RU486 29 ± 1.2 46 ± 0,6^ 70 ± 0.9 
RU 486 + relaxin 27 + 0.9" 49 ± 0.7 71 ± 0.4* 
Diluent 32 ± 1.1 50 ± 0.9 75 ± 1.3 
*P < 0.05, **P < 0.25, and *P < 0.01 compared with diluent-treated controls; 
values are mean ± SE. 
Table 3. Effects of RU 486 alone and combined with relaxin on parturition and placenta 
delivery in beef heifers 
Heifers with 
Delivery of placenta 
Heifers Dystocia > 24 h postpartum 
(n) No. % No. % 
RU486 7 1 14 2 29 
RU 486 + relaxin 7 2 29 6 86 
Diluent 7 4 57 0 0 
Table 4. Effects of RU 486 on progesterone concentration in peripheral plasma of late pregnant beef cattle 
Progesterone in peripheral plasma, ng / ml 
Pretreatment Post-treatment 
Cows Days 270 Day 277 Day 278 
(n) to 276 1200 h 2000 h 2400 h 1200 h 2000 h 2400 h 
RU486 6 8.2 ±0.6 7.210.5 6.6 + 0.5 8.1 ±0.3 4.1 ±0.6* 2.4 ± 0.4** 1.8 ±0.2^ 
RU 486 + relaxin 6 8.2 + 0.6 5.8 ±0.7 5.2 + 0.7 5.4 + 0.6 4.6 ±0.5* 3.3 ±0.4** 2.5 ± 0.4' 
Diluent 6 8.2 + 0.6 6.5+0.7 7.0 + 0.7 6.8 ±0.5 6.8 ±0.6 5.7 ±0.4 6.0 ±0.7 
*P < 0.05, < 0.025, and < 0.01 compared with diluent-treated controls; values are mean ± SE. 
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Discussion 
Administration of the progesterone antagonist RU 486 to late pregnant crossbred 
heifers precisely modified the time of delivery in this experiment. This finding is consistent 
with a recent report by Li et al. (1991b) who observed controlled timing of parturition in late 
pregnant beef cows after treatment with RU 486 alone or in combination with relaxin. These 
results may be explained by the withdrawal of progesterone dominance because RU 486 
administration was followed by a significant decline in plasma progesterone concentrations 
(Table 4). Parturition in hormone-treated heifers was preceded by a sharp decline in 
progesterone levels and the treatment-parturition interval was markedly shorter compared 
with the diluent treated controls. In cattle, the pelvic area increases steadily as pregnancy 
advances, and the rate of increase is even accelerated a few days before parturition; the 
increase near parturition coincides with the increasing concentration of 173-estradiol and 
estrone in the peripheral blood (Price and Wiltbank, 1978; Musah et al., 1986). The presence 
of progesterone and increasing estrogen concentrations at this stage of gestation may play a 
role in eliciting PG F2a induced luteolysis. In the ewe, progesterone and estrogen are 
responsible for regulating development and responsiveness of the uterine oxytocin receptor 
(Lau et al., 1992). In the ewe, oxytocin initiates the release of PG F2a (for luteolysis) fi^om 
the endometrium during the estrous cycle (Silvia et al., 1991). Burgess et al. (1992) reported 
that treatment of late-pregnant ewes with RU 486 causes an increase in myometrial activities 
and prostaglandin secretion. These authors also reported premature delivery in RU 486-
treated ewes but none of the vehicle-treated ewes experienced premature delivery. In 
pregnant rats, a single dose of mifepristone (2 mg/kg B.W.) sc, on day 15 stimulated uterine 
contratility and also increased PGE-2 and PG F2a, however the RU 486 induced uterine 
contractility occurred before the changes in uterine PGE-2 and PG F2a were observed 
(Arkaravichien and Kendle, 1992). Heifers that calve at 2 years of age are more likely to 
experience diflScult birth (dystocia) than 3-year old heifers because they have smaller pelvic 
areas (still developing) (Laster et al., 1973). Management at or near calving particularly for 2 
year old heifers is important not only for the survival of the newborn but also for the 
subsequent reproductive performance of the dam. It has been clearly shown in cattle (Musah 
et al., 1986, 87; Bagna et al., 1991) and rats (O'Day et al., 1989) that administration of relaxin 
during late pregnancy increases pelvic area and cervical dilation. The modeling of the uterine 
connective tissues and birth canal following relaxin treatment was accompanied by a much 
earlier decline in plasma progesterone concentration, earlier parturition, and decreased 
incidence of dystocia in treated heifers compared with placebo-treated animals, maternal 
behavior was normal in all animals (Musah et al., 1986; Bagna et al., 1991). Furthermore, 
relaxin in combination with cloprostenol or dexamethasone facilitates calving by shortening 
the period from beginning of labor to expulsion of fetus, decreases incidence and severity of 
dystocia and also decreases cases of retained placenta in beef heifers (Musah et al., 1987a, 
87b). This study shows that injection of RU 486 alone or in combination with relaxin in 
primiparous beef heifers during late pregnancy reduces the incidence of dystocia compared 
with vehicle-treated heifers. The calves were vigorous at birth, however hormone-treated 
heifers tended to have a longer duration of retained placenta. This observation disagrees with 
Li et al. (1991b) who reported no difference in time between calving and placenta delivery in 
hormone-treated multiparous cows compared with diluent-treated controls. Interestingly, the 
group that had most cases of dystocia was the placebo-treated controls. This could mean that 
hormone treatment alleviates the problem of difficult birth by inducing earlier birth (small 
calves) or by the biological actions of relaxin in remodeling the pelvic and cervical connective 
tissue. Moreover, in a recent study by Perusquia and Kubli-Grarfias (1994), RU 486 was 
demonstrated to have a relaxant effect on rat uterine muscle. These authors attributed the 
relaxin effects of RU 486 on its steroid moiety and hypothesized the possibility of mifepristone 
having common physio-chemical properties with progesterone. In depolarized rat 
myometrium, RU 486 blocks the calcium-induced contraction (Perusquia and Kubli-Garfias, 
1994). It is also important to recall that RU 486 exhibits progesterone properties at low 
progesterone concentration and/or low PR concentration (Gravanis et al., 1985; Koering et 
al., 1986). It is possible, though not likely, that RU 486 contributed to the reduced incidence 
of dystocia by acting as relaxant on myometrial tissue of these heifers. A number of studies 
using RU 486 demonstrated that when given in late pregnancy to pigs (Li et al., 1993), sheep 
(Burguess et al., 1992; Gazal et al., 1993), and cattle (Li et al., 1991b) RU 486 induces earlier 
delivery with healthy newbom(s) and normal subsequent reproductive performance. 
Despite elaborate research on RU 486, the mechanism of antagonistic actions of this 
synthetic steroid is yet to be determined. It appears that treatment with RU 486 initiates 
complex hormonal changes that favor the onset of labor in pregnant and antifertility events in 
nonpregnant animals. Antiprogestins enhance responsiveness of smooth muscles of the 
myometrium to contractile agents like prostaglandin and oxytocin (Elger et al., 1986). The 
effects of oxytocin in modifying the uterine cervix is improved by pretreatrnent with RU 486. 
Wolf et al. (1989) reported increased sensitivity to oxytocin of myometrial and cervical tissue 
in pregnant monkeys after treatment with RU 486. The myometrial sensitivity is associated 
with the formation of gap junctions which provide a cell-cell communication route in the 
smooth muscle of the myometrium for passage of electrical signals essential for 
synchronization of contractile activity (Chow and Lye, 1994). According to Saito et al. 
(1985), in the rat formation of gap junctions is induced by declining circulating progesterone 
levels and increasing estrogen levels during mid- to late-pregnancy (also PR and ER decrease 
and increase, respectively). In late pregnant beef heifers (Musah et al., 1986) progesterone 
concentration declined and plasma estrogen level increased when these heifers were treated 
with purified porcine relaxin. In the present study, it is possible that the decline in plasma 
progesterone concentration after treatment with RU 486 causes formation of gap junctions 
that facilitated myometrial contraction during labor. It has also been shown (Secchi et al., 
1985) that RU 486 treatment has an indirect effects on prostaglandin production. 
In summary, the study shows that administration of RU 486 alone or in combination 
with relaxin precisely controls the time of parturition in first-calf heifers. Treatment with RU 
486 results in smaller yet vigorous calves and reduces the incidence of dystocia. However, the 
incidence of retained placenta beyond 24 h occurred in RU 486-treated beef heifers, whereas 
diluent-treated controls experienced no prolonged retained placenta. 
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GENERAL SUMMARY 
After hysterectomy and during pregnancy in the pig, the corpora lutea produce both 
relaxin and progesterone. Progesterone is responsible for the establishment and maintenance 
of pregnancy, blood concentrations of progesterone peak early (day 8) and remain elevated 
until several days before parturition, then begin to decline. In contrast, relaxin concentrations 
increase with advancing pregnancy and reach peak levels a few days before parturition. Some 
of relaxin's functions include remodeling collagen fibers, stimulating uterine growth and 
inhibiting uterine contractility. 
In the first experiment, the secretory patterns of relaxin and progesterone by corpora 
lutea of pregnant and hysterectomized pigs are established. It appears that in Meishan gilts 
(like in Yorkshire gilts) there is a decrease in progesterone concentrations, while relaxin levels 
increase during late pregnancy and these events occur in hysterectomized gilts at comparable 
reproductive periods. The synchronized occurrence of hormone secretion suggests a 
preprogrammed control of events that may originate fi-om the ovary, CNS or pituitary gland. 
The difference in pituitary gland secretion of GH and PRL in hysterectomized compared with 
pregnant pigs also supports the involvement of the CNS in hormone release at parturition. 
The second study indicates that endogenous relaxin has an important role during the 
antepartum-parturition period. Relaxin is required for normal growth and extensibility of the 
reproductive tract for normal birth of piglets, enhanced parturition process and postpartum 
survival of piglets. In the third study, RU 486 caused early luteolysis and induced parturition 
in hormone-treated animals compared with diluent-treated controls. RU 486 induced earlier 
calving without the detrimental effect of dystocia in first-calf heifers, while diluent-treated 
controls had a significantly higher incidence of dystocia. It is still unclear what regulates the 
prepartum decline in progesterone levels and the subsequent relaxin surge release in the pig. 
Therefore, understanding the mechanism(s) by which these occur are of great research interest 
and should continue to be the subject of intense research effort. The ability of RU 486 to bind 
to the PR offers two possible uses of this compound: 1) provides a tool that can be used in 
understanding steroid hormone function at the molecular level, and 2) precise determination of 
the site(s) at which RU 486 acts in antagonizing progesterone action. Several hypotheses 
have emerged concerning the possible sites of RU 486 action and testing the validity of these 
ideas may lead to extended application of antisteroid compounds. 
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APPENDIX. 
Table 1. Progesterone concentrations in peripheral plasma of hysterectomized Meishan gilts, 
ng/ml 
Gilt Day 
No. -16 -15 -14 -13 -12 -11 -10 -9 
255 22.14 21.70 28.14 31.91 27.64 26.01 27.44 29.63 
272 24.16 19.67 25.71 31.45 29.76 28.41 28.43 28.77 
327 26.65 25.78 27.13 29.69 24.83 26.86 27.01 27.91 
471 20.79 26.81 24.40 37.41 25.97 28.39 27.63 26.84 
495 25.65 24.61 26.59 37.76 34.10 31.44 30.14 31.64 
512 27.13 27.01 28.67 39.81 25.76 26.11 27.56 33.66 
3020 23.61 19.13 24.89 40.36 27.86 27.46 29.49 27.96 
3030 26.41 21.16 27.61 40.61 30.71 29.04 30.51 28.45 
3033 25.36 24.19 26.91 35.45 28.75 29.49 29.81 28.82 
3034 23.73 25.09 24.51 34.90 29.48 27.42 28.63 29.63 
3035 28.16 21.64 28.09 41.61 27.77 29.91 29.71 30.11 
X 
SE 
24.95 
2.60 
23.26 
2.54 
26.59 
2.66 
36.44 
3.67 
28.51 
4.28 
28.26 
3.51 
28.73 
2.02 
29.40 
4.36 
Pig No. -2.5 -2 -1.5 -1 
o
 1 0 0.5 1 1.5 
255 18.99 25.79 16.99 15.18 19.84 15.63 9.98 16.44 18.71 
272 21.56 17.01 24.38 16.98 16.60 14.11 15.54 15.54 14.12 
327 24.63 13.76 20.38 16.02 17.10 17.63 17.98 19.62 19.20 
471 25.61 12.57 24.17 18.88 13.48 11.95 21.08 15.25 22.62 
495 23.03 25.44 18.47 24.42 22.95 19.41 22.66 10.51 22.35 
512 24.91 32.76 24.04 14.15 10.90 16.80 14.61 24.14 11.77 
3020 19.65 14.96 21.64 7.73 10.14 17.66 12.18 11.98 15.86 
3030 23.66 16.32 23.74 13.36 21.14 15.94 13.62 18.17 19.45 
3033 17.14 17.26 17.28 11.60 19.38 14.91 16.89 18.79 19.51 
3034 21.99 22.12 21.21 16.68 16.82 16.45 14.96 18.02 19.00 
3035 19.66 15.52 19.10 10.61 19.03 23.44 12.61 14.38 12.96 
X 21.91 19.05 21.07 15.05 17.91 16.73 15.62 16.84 17.75 
SE 5.69 3.93 5.61 4.08 4.52 4.36 3.16 3.21 3.02 
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Day 
-8 -7 -6 -5.5 -5 -4,5 -4 -3.5 -3 
29.78 28.16 30.63 21.41 22.34 19.67 26.50 25.94 24.91 
31.88 27.43 33.76 27.91 27.71 18.43 27.67 26.13 19.67 
30.19 26.01 30.89 26.11 22.67 21.43 24.45 24.96 24.14 
30.81 26.91 29.63 29.78 27.59 23.17 20.33 23.78 20.83 
30.06 24.61 33.91 24.11 24.76 17.94 23.86 21.91 18.21 
28.89 29.41 28.71 24.94 23.96 20.21 26.45 25.43 24.93 
29.49 27.61 30.11 26.76 24.51 21.63 23.68 24.91 25.88 
30.77 29.51 31.76 24.44 21.91 18.45 20.66 21.34 18.16 
33.71 20.70 33.41 27.63 20.76 23.91 21.96 22.84 19.45 
29.42 28.11 34.61 28.11 24.56 17.94 24.11 29.77 17.71 
27.61 24.63 27.96 22,71 25,14 19.91 25.41 20.94 23.94 
30.21 26.66 31.39 0,00 24,15 20.26 24.09 24.39 21.61 
4.10 3.95 3.67 0,00 4,11 5.95 4.99 5,39 6.34 
2 2.5 3 3.5 4 4.5 5 5,5 6 
16.29 19.79 23.92 14.06 14.36 16.06 18.81 12,13 14,13 
16.16 17.70 16.42 15.18 17.37 15.63 12.51 14,17 17,52 
19.14 22.28 16.36 12.92 14.18 14.62 19.50 16,83 20,82 
26.76 27.87 31.41 28.00 15.13 12.77 16.60 15.00 19.60 
19.93 15.86 14,58 12.83 10.21 11.44 12.84 12.72 11.45 
17.67 18.32 10.57 14.67 11.11 11.60 12.60 11.84 11.90 
15.43 15.10 16.10 18.13 19.01 10.91 12.94 15.55 12.43 
17.23 16.47 15.58 17.32 17.55 19,14 8.88 12.72 11.45 
17.11 17.85 16,16 16.13 16.83 17,72 9.64 9.53 11.45 
19.86 12.17 12.16 17.50 17.28 18,62 9.33 12.72 11.45 
18.33 19.20 9,57 16.41 16.33 17,37 7.64 9.57 9.06 
18.48 18.48 16.53 16,76 15.33 15.66 12.49 12.98 12.71 
3.85 4.21 2,12 1.89 3.19 3.06 1.82 2.02 1.92 
Table 2. Progesterone concentrations in peripheral plasma of pregnant Meishan gilts, ng/ml 
Gilt Day 
No. -16 -15 -14 -13 -12 -11 -10 -9 
254 11.65 15.91 21.18 19.11 21.43 19.87 22.16 23.43 
287 17.80 16.80 19.20 17.02 20.41 17.90 20.20 20.53 
318 14.80 18.80 20.20 18.00 19.40 21.90 17.20 16.40 
333 12.74 14.76 18.18 16.00 18.39 22.88 18.17 18.36 
334 15.82 18.76 21.16 19.05 21.38 20.89 19.24 20.43 
356 10.83 19.85 22.01 15.83 16.42 15.43 23.87 19.47 
X 13.94 17.48 20.32 17.48 19.57 19.81 20.14 19.77 
SE 1.49 1.67 1.3 2.68 2.8 1.84 2.17 1.83 
-2.5 -2 -1.5 1 1 p
 
Lh
 
0 0.5 1 1.5 
254 14.84 14.20 18.48 10.99 9.03 3.75 2.61 1.70 1.13 
287 14.50 17.30 15.30 12.90 14.10 5.19 2.19 1.46 0.80 
318 18.50 14.77 13.30 18.92 11.10 8.63 2.95 1.79 0.94 
333 19.47 17.23 18.30 17.88 8.08 6.66 2.78 1.88 1.36 
334 20.47 17.33 10.35 19.82 16.07 3.14 2.13 1.90 0.98 
356 14.50 19.31 17.33 20.41 7.14 7.49 2.91 1.35 0.89 
X 17.38 16.69 15.51 16.82 10.92 5.81 2.58 1.68 1.03 
SE 3.6 4.24 3.8 6.34 4.5 1.23 0.55 0.5 0.26 
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Day 
-8 -7 -6 -5.5 -5 -4.5 -4 -3;5 -3 
18.31 14.44 23.31 15.28 19.44 18.45 15.25 17.57 19.63 
17.90 17.46 20.42 18.20 20.50 20.40 25.30 27.50 20.70 
16.54 18.40 18.38 15.20 18.50 21.40 28.30 22.50 29.70 
15.83 20.40 17.38 15.00 20.48 19.39 15.27 27.50 20.66 
15.04 19.38 23.41 16.25 18.50 23.43 25.27 31.26 13.69 
17.90 13.09 23.82 18.23 21.38 21.91 25.30 27.57 10.72 
16.92 17.19 21.12 16.36 19.8 20.83 22.46 25.65 20.22 
1.32 1.73 4.15 3.61 3.98 6.98 8.1 7.43 7.01 
2 2.5 3 3.5 4 4.5 5 5.5 6 
1.55 1.21 0.79 0.66 0.57 0.27 0.45 0.37 0.25 
1.01 1.01 0.88 0.76 0.63 0.30 0.39 0.35 0.20 
1.14 0.95 0.66 0.56 0.48 0.47 0.44 0.30 0.19 
1.73 0.88 0.68 0.51 0.48 0.42 0.51 0.46 0.28 
0.98 0.78 0.71 0.56 0.53 0.35 0.41 0.41 0.26 
1.21 0.99 0.91 0.68 0.49 0.38 0.32 0.27 0.27 
1.23 0.97 0.76 0.62 0.53 0.36 0.42 0.36 0.24 
0.31 0.26 0.18 0.12 0.19 0.06 0.12 0.08 0.02 
Table 3. Relaxin concentration in peripheral plasma of pregnant Meishan gilts, ng/ml 
Gilt Day 
No. -16 -15 -14 -13 -12 -11 -10 -9 
287 0.8 0.6 1.01 0.8 1.4 1.9 2.41 2.4 
356 0.83 1.05 1.43 1.22 1.46 1.92 2 3.97 
333 0.74 0.77 0.97 0.7 1.39 1.66 2.02 3.36 
318 0.8 0.79 1.41 1.3 1.4 1.9 2.35 3.9 
254 0.82 0.49 0.99 0.86 1.43 2.09 2.16 3 
334 0.82 1.06 1.35 1.19 1.38 1.89 2.24 3.86 
X 0.8 0.79 1.19 1 1.41 1.89 2.19 3.41 
SE 0.08 0.06 0.33 0.11 0.18 0.36 0.39 0.56 
-2.5 -2 -1.5 -1 -0.5 0 0.5 1 
287 9.5 14.3 29.3 35.9 60.1 20.7 9.7 1.96 
356 13.5 20.31 20.33 45.93 72.14 28.71 5.7 2.45 
333 11.47 17.23 26.3 40.88 59.08 19.69 5.64 2.16 
318 8.51 15.3 27.3 36.9 73.1 26.7 9.74 1.86 
254 14.53 19.2 28.3 44.99 58.03 26.8 7.76 2.38 
334 11.47 17.33 20.35 40.84 74.19 20.72 7.7 2.22 
X 11.55 17.28 25.31 40.91 66.1 24.72 7.71 2.18 
SE 3.16 4.29 3.69 2.14 10.9 5.68 2.86 0.67 
122 
Day 
-8 -7 -6 -5.5 -5 -4.5 -4 -3.5 -3 
4.81 3.4 2.4 4.2 3.5 3.4 4.3 6.34 8.7 
2.96 5.41 4.42 3 3.5 5.44 6.31 8.57 10.72 
3.01 4.4 3 3.4 2.48 3.39 6.27 5.49 7.66 
4.71 3.41 3.78 2.2 4.5 5.4 4.31 9.51 11.7 
2.86 5.47 3.61 4.28 3.44 4.45 4.25 5.57 10.63 
4.93 4.36 3.11 2.25 3.5 4.43 6.27 9.48 9.69 
3.9 4.41 3.41 3.22 3.51 4.42 5.3 7.52 • 9.73 
0.73 0.88 0.59 0.81 0.58 1.21 1.18 1.73 2.44 
1.5 2 2.5 3 3.5 4 4.5 5 5.5 6 
0.8 0.4 0.3 0.31 0.3 0.3 0.2 0.3 0.2 0.16 
0.66 0.62 0.31 0.52 0.33 0.32 0.21 0.3 0.23 0.24 
0.79 0.49 0.27 0.34 0.29 0.3 0.16 0.27 0.18 0.19 
0.94 0.45 0.26 0.39 0.3 0.3 0.2 0.3 0.22 0.22 
0.6 0.55 0.34 0.4 0.27 0.31 0.23 0.23 0.17 0.18 
0.92 0.59 0.3 0.5 0.28 0.29 0.25 0.28 0.23 0.2 
0.78 0.51 0.31 0.42 0.3 0.31 0.21 0.31 0.2 0.2 
0.14 0.1 0.03 0.11 0.02 0.01 0.01 0.02 0.01 0.02 
Table 4. Relaxin concentration in peripheral plasma of hysterectomized Meishan gilts, ng/ml 
Gilt. Day 
No -16 -15 -14 -13 -12 -11 -10 -9 
255 2.9 3.49 3.39 4.34 4.99 5.33 4.2 8.12 
272 2.82 3.67 4.24 4.75 5.35 7.27 6.32 6.22 
327 2.98 3.63 4.57 4.85 5.19 6.34 4.23 7.19 
471 2.88 3.55 4.42 5.26 4.21 6 6.2 7.01 
495 2.79 3.49 4.37 4.88 5.25 6.48 6.34 8.17 
512 2.81 3.66 4.77 4.77 6.18 6.72 4.22 6.07 
3020 2.83 3.54 4.26 3.54 5.18 6.29 5.17 9.19 
3030 2.86 3.48 4.33 4.79 5.23 5.99 5.22 5.01 
3033 2.89 3.59 4.37 5.87 4.14 6.59 6.29 7.28 
3034 2.94 3.63 4.32 4.99 5.21 6.35 5.18 7.14 
3035 3.42 3.98 3.98 4.81 6.11 6.31 5.22 7.11 
X 2.92 3.61 4.31 4.81 5.19 6.33 5.23 7.14 
SE 0.48 0.37 0.6 0.55 0.4 0.42 1.72 1.62 
-2.5 -2 -1.5 -1 -0.5 0 0.5 1 
255 10.94 12.79 15.99 15.18 34.1 9.98 16.44 18.71 
272 16.74 15.54 15.38 18.98 30.48 27.54 15.54 14.22 
327 12.76 13.71 12.38 22.79 26.19 17.9 19.62 19.2 
471 10.51 12.51 14.27 18.88 33.1 21.08 20.25 22.62 
495 13.79 15.44 18.47 24.42 30.36 22.66 10.51 22.35 
512 11.87 12.76 14.97 14.15 67.49 26.61 24.14 11.77 
3020 13.27 14.96 12.64 19.73 16.64 2.18 1.98 5.86 
3030 16.61 6.97 13.77 13.32 28.45 8.62 8.23 9.45 
3033 16.72 12.26 14.36 21.63 50.58 26.89 8.79 9.51 
3034 16.34 12.12 11.21 16.68 34.01 19.96 18.02 9 
3035 15.91 15.52 19.14 17.6 23.34 7.61 7.37 8.95 
X 14.86 13.12 14.78 18.76 34.06 17.36 13.71 12.9 
SE 2.47 1.44 1.44 3.53 4.18 2.67 2.04 1.96 
124 
Day 
-8 -7 -6 -5.5 -5 -4.5 -4 -3.5 -3 
11.26 6.22 6.63 5.36 5.94 7.05 10.13 10.17 11.43 
7.15 9.16 10.62 12.15 10.52 5.25 9.32 14.75 18.35 
9.31 8.21 8.68 13.25 9.24 12.9 15.78 22.58 11.43 
6.18 9.2 7.56 2.62 2.67 14.71 11.73 8.62 11.7 
10.27 8.22 9.67 11.25 13.76 12.35 12.07 12.57 10.14 
9.38 6.25 5.57 7.8 6.77 6,22 7.89 8.89 11.89 
11.25 8.12 11.62 7.28 9.19 5.65 13.39 16.96 13.11 
9.19 10.18 8.62 8.66 12.53 9.37 16.23 8.29 13.95 
7.15 8.16 7.58 2.17 4.5 14.3 12.19 12.33 8.44 
10.15 6.22 9.58 6.18 3.29 14.24 12.77 10.14 8.66 
10.21 10.12 8.62 8.75 7.05 5.93 5.88 16.16 6.47 
9.23 8.19 8.61 7.77 7.77 9.99 11.58 12.86 11.34 
1.66 1.16 1.7 1.09 1 1.28 1.49 1.61 1.57 
1.5 2 2.5 3 3.5 4 4.5 5 5.5 6 
16.29 19.79 23.92 4.06 4.36 16.16 18.81 12.13 8.85 18.2 
13.19 17.74 16.42 15.18 17.37 15.63 12.51 14.17 7.52 17.52 
19.14 22.28 16.36 10.92 17.18 14.62 19.53 16.79 20.77 20.77 
26.76 27.87 31.41 28 15.13 12.77 16.6 15.1 19.64 19.64 
10.93 15.86 14.58 10.83 10.21 11.44 12.84 12.72 11.45 11.45 
17.67 8.32 6.57 14.67 11.11 11.6 12.6 11.84 11.9 11.9 
5.43 5.1 6.1 8.13 9.01 9.91 12.94 15.55 2.43 2.43 
7.18 6.47 7.58 7.32 7.55 9.35 8.88 12.72 11.45 11.45 
7.11 7.85 6.16 6.13 6.83 7.72 9.64 9.53 11.45 11.45 
9.86 2.17 2.16 7.5 7.28 9.62 9.33 12.72 11.45 11.46 
8.33 9.2 9.57 6.41 6.33 7.37 7.64 6.68 9.06 9.06 
12.9 12.96 12.8 10.83 10.21 11.44 12.84 12.72 11.45 12.17 
1.96 2.46 2.65 2.23 1.5 1.01 1.33 1.19 2.51 1.51 
Table 5. Prolactin concentration in peripheral plasma of pregnant Meishan gilts, ng/ml 
Gilt Day 
No. -16 -15 -14 -13 -12 -11 -10 -9 
255 4.60 4.21 4.40 3.24 4.13 3.52 4.80 4.27 
272 4.53 4.19 4.39 4.58 2.87 14.74 7.41 5.99 
327 4.51 4.16 4.11 4.77 5.74 8.29 7.19 6.84 
471 4.48 4.24 4.56 4.65 5.78 8.32 3.93 3.29 
495 5.09 4.16 4.39 5.69 10.18 10.27 13.31 7.52 
512 4.61 4.25 4.33 4.95 5.89 4.71 6.51 13.15 
X 4.64 4.21 4.38 4.63 5.76 8.31 7.19 6.84 
SE 0.31 0.36 0.29 0.32 1.01 1.64 1.34 1.42 
-2 -1.5 -1 -0.5 0 0.5 1 1.5 
254 5.86 5.04 5.57 4.57 3.44 2.99 3.57 2.73 
287 7.50 3.24 6.91 4.55 9.57 10.90 8.70 18.70 
318 3.86 2.98 2.64 3.36 3.83 3.64 3.49 4.94 
333 2.15 2.17 1.63 2.29 2.27 2.11 2.29 1.63 
334 6.44 4.37 3.06 4.87 3.46 3.76 3.01 4.07 
356 1.47 2.46 5.39 5.14 2.49 1.86 7.29 3.13 
X 4.55 3.38 4.20 4.13 4.17 4.21 4.72 5.87 
SE 0.99 0.45 0.84 0.44 1.10 1.37 1.06 2.60 
126 
Day 
-8 -7 -6 -5 -4.5 -4 -3.5 -3 -2.5 
3.75 3.94 4.85 3.43 3.70 5.09 4.79 4.61 6.72 
4.21 2.96 9.51 8.40 12.42 7.00 7.12 5.46 6.95 
13.16 5.45 3.99 4.37 4.90 4.32 4.08 4.39 4.25 
3.66 4.04 3.39 3.86 3.37 2.94 2.96 2.27 2.07 
4.96 4.17 4.45 5.90 3.10 5.73 7.28 2.90 2.53 
5.26 4.35 3.12 3.55 1.77 6.87 7.70 2.45 2.50 
5.83 4.15 4.88 4.92 4.87 5.33 5.65 3.68 4.17 
1.49 0.33 0.96 0.78 1.56 0.63 0.80 0.54 0.89 
2 2.5 3 3.5 4 4.5 5 5.5 6 
4.45 4.43 10.18 10.07 4.75 4.58 9.37 3.60 3.50 
8.17 7.96 5.33 5.64 4.37 3.61 5.05 4.83 3.50 
5.14 4.92 4.41 4.00 4.13 4.36 3.88 9.84 3.45 
2.77 2.13 2.04 1.87 2.03 1.96 2.69 2.52 2.07 
2.45 2.44 3.35 2.84 3.72 3.60 5.99 4.37 3.61 
6.14 2.64 2.88 2.07 3.95 4.15 3.39 3.82 4.88 
4.85 4.09 4.70 4.42 3.83 3.71 5.06 4.83 3.50 
0.87 0.90 1.19 1.26 0.39 0.38 1.10 1.29 0.44 
Table 6. Prolactin concentration in peripheral plasma of hysterectomized Meishan gilts, 
ng/ml® 
Gilt. Day 
No -16 -15 -14 -13 -12 -11 -10 -9 
255 4.60 4.21 4.40 3.24 4.13 3.52 4.80 4.27 
272 4.53 4.19 4.39 4.58 2.87 14.74 7.41 5.99 
327 4.51 4.16 4.11 4.77 5.74 8.29 7.19 6.84 
471 4.48 4.24 4.56 4.65 5.78 8.32 3.93 3.29 
495 5.09 4.16 4.39 5.69 10.18 10.27 13.31 7.52 
512 4.61 4.25 4.33 4.95 5.89 4.71 6.51 13.15 
X 4.64 4.21 4.38 4.63 5.76 8.31 7.19 6.84 
SE 0.31 0.36 0.29 0.32 1.01 1.64 1.34 1.42 
-2 -1.5 -1 -0.5 0 0.5 1 1.5 
255 5.86 5.04 5.57 4.57 3.44 2.99 3.57 2.73 
272 7.50 3.24 6.91 4.55 9.57 10.90 8.70 18.70 
327 3.86 2.98 2.64 3.36 3.83 3.64 3.49 4.94 
471 2.15 2.17 1.63 2.29 2.27 2.11 2.29 1.63 
495 6.44 4.37 3.06 4.87 3.46 3.76 3.01 4.07 
512 1.47 2.46 5.39 5.14 2.49 1.86 7.29 3.13 
X 4.55 3.38 4.20 4.13 4.17 4.21 4.72 5.87 
SE 0.99 0.45 0.84 0.44 1.10 1.37 1.06 2.60 
''Nongravid gilts were hysterectomized on day 8 after estrus, and corpora lutea were marked 
with black silk suture for later identification 
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Day 
-8 -7 -6 -5 -4.5 -4 -3.5 -3 -2.5 
3.75 3.94 4.85 3.43 3.70 5.09 4.79 4.61 6.72 
4.21 2.96 9.51 8.40 12.42 7.00 7.12 5.46 6.95 
13.16 5.45 3.99 4.37 4.90 4.32 4.08 4.39 4.25 
3.66 4.04 3.39 3.86 3.37 2.94 2.96 2.27 2.07 
4.96 4.17 4.45 5.90 3.10 5.73 7.28 2.90 2.53 
5.26 4.35 3.12 3.55 1.77 6.87 7.70 2.45 2.50 
5.83 4.15 4.88 4.92 4.87 5.33 5.65 3.68 4.17 
1.49 0.33 0.96 0.78 1.56 0.63 0.80 0.54 0.89 
2 2.5 3 3.5 4 4.5 5 5.5 6 
4.45 4.43 10.18 10.07 . 4.75 4.58 9.37 3.60 3.50 
8.17 7.96 5.33 5.64 4.37 3.61 5.05 4.83 3.50 
5.14 4.92 4.41 4.00 4.13 4.36 3.88 9.84 3.45 
2.77 2.13 2.04 1.87 2.03 1.96 2.69 2.52 2.07 
2.45 2.44 3.35 2.84 3.72 3.60 5.99 4.37 3.61 
6.14 2.64 2.88 2.07 3.95 4.15 3.39 3.82 4.88 
4.85 4.09 4.70 4.42 3.83 3.71 5.06 4.83 3.50 
0.87 0.90 1.19 1.26 0.39 0.38 1.10 1.29 0.44 
Table 7. Growth hormone concentration in peripheral plasma of pregnant Meishan gilts, 
ng/ml 
Gilt Day 
No. -16 -15 -14 -13 -12 -11 -10 -9 
254 0.46 0.84 0.72 1.23 0.74 1.34 0.34 0.49 
287 0.54 0.69 0.89 1.01 0.83 1.19 0.52 0.46 
318 0.48 0.70 0.86 0.99 0.64 1.24 0.32 0.58 
333 0.59 0.71 1.11 1.12 0.72 1.28 0.41 0.51 
334 0.59 0.64 1.64 1.01 0.79 1.04 0.72 0.60 
356 0.47 0.83 0.79 1.21 0.61 0.99 0.38 0.66 
X 0.52 ' 0.74 1.00 1.10 0.72 1.18 0.45 0.55 
SE 0.03 0.03 0.14 0.04 0.03 0.06 0.06 0.03 
-2.5 -2 -1.5 -1 
C
) 
1 0 0.5 1 1.5 
254 0.79 1.57 0.59 1.09 0.94 0.99 0.73 1.32 1.09 
287 0.68 1.38 0.64 0.98 1.02 1.09 0.76 1.46 0.94 
318 0.74 1.48 0.67 0.89 1.04 1.01 0.88 1.46 0.99 
333 0.72 1.39 0.60 0.84 0.96 1.31 0.81 1.39 1.12 
334 0.72 1.36 0.64 1.19 1.10 2.76 0.84 1.42 1.13 
356 0.66 1.59 0.58 1.41 1.08 0.84 0.78 1.51 1.19 
X 0.72 1.46 0.62 1.07 1.02 1.33 0.80 1.43 1.08 
SE 0.02 0.04 0.01 0.09 0.03 0.29 0.02 0.03 0.04 
130 
Day 
-8 -7 -6 -5.5 -5 -4.5 -4 -3.5 -3 
0.54 0.63 0.85 0.79 0,95 0.69 0.83 0.51 0.59 
0.54 0.66 0.77 0.84 0.99 0.55 1.11 0.54 0.74 
0.59 0.53 0.64 0.78 0.77 0.59 1.08 0.52 0.61 
0.64 0.52 0.74 0.84 0.79 0.64 0.93 0.61 0.72 
1.00 0.56 0.98 0.80 0.83 0.63 1.00 1.38 1.08 
0.46 0.58 0.62 0.81 0.86 0.55 0.99 0.58 0.86 
0.63 0.58 0.77 0.81 0.87 0.61 0.99 0.69 0.77 
0.08 0.02 0.05 0.01 0.04 0.02 0.04 0.14 0.07 
2 2.5 3 3.5 4 4.5 5 5.5 6 
1.15 2.45 1.44 2.49 1.89 3.80 4.41 2.94 2.71 
1.28 2.49 1.48 2.59 1.98 3.77 3.89 2.79 2.58 
1.29 2.66 1.32 2.62 2.14 3.86 4.93 2.88 2.70 
1.19 2.51 1.39 2.47 2.06 3.79 3.91 2.77 2.61 
1.24 2.54 1.42 2.56 2.11 3.82 3.94 2.86 2.63 
1.11 2.58 1.50 2.44 2.01 3.96 0.00 0.00 0.00 
1.21 2.54 1.43 2.53 2.03 3.83 3.51 2.37 2.21 
0.03 0.03 0.03 0.03 0.04 0.03 0.18 0.04 0.04 
Table 8. Growth hormone concentration in peripheral plasma of hysterectomized Meishan 
gilts, ng/ml 
Gilt Day 
No. -16 -15 -14 -13 -12 -11 -10 -9 
255 0.53 0.84 1.21 0.49 1.51 0.93 0.88 1.26 
272 0.49 0.63 0.94 0.52 1.43 0.79 0.92 1.14 
327 0.58 0.50 1.01 0.56 1.38 0.81 1.03 1.13 
471 0.45 0.74 1.01 0.58 1.41 0.80 0.85 1.23 
495 0.52 0.64 1.19 0.49 1.32 0.77 0.96 1.31 
512 0.63 0.60 0.99 0.63 1.50 0.97 0.93 1.24 
X 0.53 0.66 1.06 0.55 1.43 0.85 0.93 1.22 
SE 0.02 0.05 0.05 0.02 0.03 0.03 0.03 0.03 
-2.5 -2 -1.5 -1 -0.5 0 0.5 1 1.5 
255 0.56 0.63 1.34 0.71 0.49 1.01 0.56 0.56 0.46 
272 0.46 0.78 1.93 0.81 0.43 0.91 0.64 0.49 0.56 
327 0.48 0.73 1.68 0.56 0.53 0.66 0.61 0.66 0.51 
471 0.54 0.69 1.58 0.96 0.56 0.54 0.58 0.70 0.44 
495 0.56 0.87 1.54 0.49 0.58 0.91 0.64 0.65 0.50 
512 0.43 0.91 1.66 0.61 0.46 0.58 0.68 0.71 0.53 
X 0.51 0.77 1.62 0.69 0.51 0.77 0.62 0.63 0.50 
SE 0.02 0.04 0.08 0.07 0.02 0.08 0.01 0.03 0.02 
132 
Day 
-8 -7 -6 -5.5 -5 -4.5 -4 -3.5 -3 
0.74 1.29 1.09 0.67 0.89 1.48 0.69 0.81 1.01 
0.84 1.14 1.19 0.73 0.94 1.34 0.78 0.79 1.11 
0.69 1.38 1.16 0.66 1.16 1.44 0.88 0.86 0.89 
0.61 1.21 0.99 0.74 0.84 1.38 0.74 0.78 0.91 
0.68 1.11 0.89 0.75 1.04 1.48 0.69 0.84 0.78 
0.71 0.99 1.13 0.78 1.16 1.36 0.98 0.79 1.21 
0.71 1.19 1.08 0.72 1.01 1.41 0.79 0.81 0.99 
0.03 0.06 0.05 0.02 0.06 0.02 0.05 0.01 0.06 
2 2.5 3 3.5 4 4.5 5 5.5 6 
0.86 1.37 1.11 0.53 0.39 1.26 3.94 0.61 0.89 
0.79 1.09 0.96 0.56 0.47 1.08 2.18 0.65 0.93 
0.83 1.48 1.23 0.53 0.56 1.34 2.09 0.74 1.08 
0.78 1.18 1.01 0.61 0.38 1.22 1.98 0.59 0.99 
0.87 1.46 0.88 0.58 0.56 1.19 1.98 0.78 0.94 
0.93 1.39 0.99 0.49 0.58 1.32 2.16 0.68 0.86 
0.84 1.33 1.03 0.55 0.49 1.24 2.39 0.68 0.95 
0.02 0.06 0.05 0.02 0.04 0.04 0.1 0.03 0.03 
Table 9. Relaxin concentration in peripheral plasma of Yorkshire gilts treated antipRLX540, 
ng/ml 
Day 
Gilt No. -12.5 -12 -11.5 -11 -10.5 -10 -9.5 -9 -8.5 
1386 0.61 0.47 0.34 0.88 1.03 0.79 0.76 2.06 2.62 
1410 0.78 0.47 0.37 0.88 1.03 0.78 0.76 1.16 1.82 
1431 0.59 0.51 0.34 0.62 0.83 1.01 0.71 1.35 1.28 
1455 0.78 0.47 0.31 0.87 1.03 0.79 0.76 1.16 0.84 
1458 0.78 0.51 0.34 0.88 1.03 0.79 0.76 1.2 0.58 
1462 0.96 0.44 0.37 0.88 1.03 0.79 0.76 0.56 0.28 
1475 0.78 0.47 0.31 1.45 2 0.69 0.81 0.64 1.15 
1481 0.78 0.51 0.34 0.87 1.03 0.79 0.76 1.16 3.36 
1483 0.97 0.38 0.37 0.56 0.49 0.56 1.11 1.17 1.5 
1484 0.78 0.47 0.34 0.87 0.82 0.9 0.41 1.18 4.77 
X 0.78 0.47 0.34 0.88 1.03 0.79 0.76 1.16 1.82 
SE 0.19 0.04 0.03 0.29 0.33 0.1 0.14 0.19 0.49 
-3 -2.5 -2 -1.5 -1 -0.5 0 0.5 1 
1386 2.84 7.13 13.85 14.29 61.11 8.14 6.03 0.69 0.26 
1410 4.6 12.92 13.7 28.06 10.26 87.08 11.38 0.81 2.17 
1431 4.43 10.09 13.5 12.45 22.04 61.44 3.17 0.86 0.66 
1455 18.76 16.22 5.32 28.85 71.53 45.25 1.48 0.25 0.25 
1458 10.03 11.9 10.13 29.09 30.02 39.37 2.99 0.38 0.25 
1462 7.23 6.41 13.12 11.31 26.24 16.64 1.35 0.59 0.25 
1475 13.78 11.76 18.09 22.22 60.32 8.44 5.41 1.15 0.25 
1481 11.67 17.73 19.85 24.38 47.75 18.48 3.97 0.25 0.25 
1483 13.48 11.17 35.55 21.41 87.54 50.28 7.77 1.61 0.25 
1484 10.52 13.64 17.6 22.07 33.88 49.23 0.76 0.25 0.25 
X 9.73 11.9 16.07 21.41 45.07 38.43 4.43 0.71 0.48 
SE 1.58 1.25 2.53 2.36 7.78 8.09 0.99 0.13 0.19 
134 
Day 
-8 -7.5 -7 -6.5 -6 -5.5 -5 -4.5 -4 -3.5 
1.65 0.72 0.78 1.04 0.99 1.44 4.35 2.87 3.94 8.37 
1.67 0.49 0.65 0.47 0.57 0.79 0.95 1.69 2.61 7.01 
5.37 5.4 6.8 2.24 3.95 1.58 1.33 16.76 11.69 3.04 
0.36 0.35 0.37 0.39 0.69 0.77 0.82 2.29 4.64 14.02 
0.8 1.3 2.05 1.87 3.85 3.55 5.5 15.09 4.9 3.05 
0.34 0.8 2.15 2.53 2.08 3.41 3.04 2.66 7.79 6.45 
1.03 3.79 5.74 5.45 5.19 5.12 4.17 4.27 4.56 9.41 
1.63 1.72 3.36 6.3 6.89 9.51 8.03 9.48 9.76 10.92 
2.33 2.48 9.08 3.39 3.09 2.07 2.47 2.63 3.59 2.77 
1.5 1.42 1.59 1.71 2.21 2.37 2.46 4.4 5.6 9.18 
1.67 1.85 2.44 2.54 2.95 3.06 3.32 4.85 5.71 7.42 
0.51 0.51 0.7 0.63 0.65 0.83 0.71 1.51 0.9 1.18 
1.5 2 2.5 3 3.5 4 4.5 5 5.5 6 
0.25 0.24 0.27 0.22 0.25 0.24 0.27 0.33 0.25 0.23 
0.25 0.24 0.24 0.22 0.25 0.24 0.27 0.33 0.27 0.25 
0.24 0.37 0.34 0.32 0.35 0.33 0.28 0.28 0.24 0.24 
0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.22 
0,25 0.24 0.24 0.22 0.25 0.25 0.27 0.33 0.25 0.26 
0.24 0.24 0.24 0.24 0.24 0.23 0.24 0.24 0.24 0.24 
0.24 0.24 0.24 0.22 0.25 0.24 0.27 0.33 0.27 0.21 
0.24 0.24 0.24 0.24 0.24 0.22 0.24 0.24 0.24 0.27 
0.24 0.24 0.24 0.24 0.24 0.26 0.24 0.24 0.24 0.24 
0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 
0.39 0.26 0.26 0.26 0.26 0.26 0.25 0.28 0.26 0.25 
0.14 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 
Table 10. Relaxin concentration in peripheral plasma of Yorkshire gilts treated with PBS, 
ng/ml 
Gilt Day 
No. -12.5 -12 -11.5 -11 -10.5 -10 -9.5 -9 -8.5 
1381 0.56 0.66 0.84 1.22 3.66 1.09 2.96 2.39 3.87 
1382 0.78 1.06 1.04 1.22 4.51 1.4 2.09 1.63 2.9 
1430 0.98 0.86 0.72 0.56 0.49 0.58 0.94 1.5 1.81 
1444 0.8 0.74 0.96 1.22 3.66 1.09 2.96 4.93 4.42 
1445 0.78 0.96 1.14 1.22 3.66 1.09 4.31 1.6 3.19 
1450 0.61 0.87 0.82 1.22 3.66 1.09 2.96 4.93 4.42 
1454 0.87 0.71 1.12 1.22 3.66 1.09 2.96 4.93 4.42 
1485 0.86 1.02 0.88 1.44 1.36 0.95 0.96 1.35 1.37 
X 0.78 0.86 0.94 1.22 3.66 109 2.96 4.93 4.42 
SE 0.21 0.45 0.3 0.34 1.77 0.2 1.08 3.24 1.82 
-3 -2.5 -2 -1.5 -1 1 P
 
0 0.5 1 
1381 8.71 6.33 11.95 19.52 58.8 44.98 4.15 0.39 0.25 
1382 11.48 12.83 9.04 19.06 25.63 40.1 4.74 1.22 1.25 
1430 16.17 15.83 25.26 11.5 12.92 52.77 0.35 0.42 0.26 
1444 11.95 9.36 22.52 15.64 17.68 38.95 6.29 0.54 0.39 
1445 11.39 14.1 14.4 3.85 40.94 38.7 4.88 1 0.5 
1450 7.74 6.3 12.51 11.56 25.63 40.1 3.97 0.75 0.55 
1454 21.8 14.63 22.8 14.31 38.3 37.68 5.59 0.97 0.45 
1485 2.59 3.58 2.54 6.62 28.02 24.1 5.48 1.38 0.9 
X 11.48 10.37 15.13 11.56 28.41 40.1 3.97 0.75 0.55 
SE 2.34 1.62 2.77 2.38 7.27 3.31 0.83 0.16 0.12 
136 
Day 
-8 -7.5 -7 -6.5 -6 -5.5 -5 -4.5 -4 -3.5 
3.92 7.12 7.06 6.59 9.75 9.59 7.34 7.77 6.96 10.9 
2.84 5.69 7.33 8.85 3.73 5.34 9.16 6.53 6.93 7.8 
3.67 3.08 6.83 4.68 4.41 4.73 5.99 5.44 10.89 7.27 
6.31 1.72 1.93 0.96 1.22 1.53 2.68 2.06 4.69 5.06 
2.96 4.96 3.73 6.62 1.27 8.76 6.47 8.67 7.97 10.31 
6.31 5.52 5.99 5.57 5.31 7.98 2.12 3.13 8.41 5.08 
6.31 5.52 5.99 5.57 5.31 6.23 5.14 7.99 2.99 9.86 
2.57 1.7 2.74 1.66 5.22 5.66 2.25 2.44 1.03 0.86 
6.31 5.52 5.99 5.57 5.31 6.23 5.14 6.53 6.93 7.14 
3.12 1.66 1.34 1.26 1.51 1.05 1.06 1.5 1.37 1.19 
1.5 2 2.5 3 3.5 4 4.5 5 5.5 6 
0.25 0.24 0.25 0.22 0.25 0.24 0.25 0.24 0.25 0.24 
0.24 0.25 0.25 0.24 0.25 0.25 0.25 0.25 0.25 0.24 
0.25 0.25 0.25 0.24 0.25 0.25 0.24 0.25 0.25 0.24 
0.25 0.25 0.25 0.24 0.25 0.25 0.24 0.25 0.25 0.24 
0.25 0.24 0.25 0.22 0.25 0.24 0.25 0.25 0.25 0.24 
0.28 0.27 0.25 0.24 0.25 0.25 0.25 0.25 0.25 0.24 
0.25 0.25 0.25 0.24 0.25 0.25 0.24 0.25 0.25 0.24 
0.47 0.36 0.25 0.39 0.25 0.25 0.26 0.25 0.25 0.24 
0.28 0.27 0.25 0.25 0.27 0.43 0.25 0.25 0.25 0.25 
0.03 0.02 0.01 0.01 0.02 0.18 0.01 0.01 0.03 0.02 
Table 11. Progesterone concentration in peripheral plasma of Yorkshire gilts treated with 
antipRLX540, ng/ml 
Gih Day 
No. -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2.5 
1386 14.85 12.45 8.16 8.64 6.69 17.37 13.76 14.42 15.62 15.72 8.78 
1410 14.85 12.45 8.16 8.64 10.25 12.30 15.60 15.10 17.00 15.50 18.70 
1431 6.00 15.10 9.34 10.40 8.36 10.20 10.70 6.18 5.01 9.36 13.60 
1455 14.85 12.45 8.16 8.64 16.60 17.40 15.60 15.40 14.00 11.60 13.90 
1458 14.85 12.45 8.16 7.73 7.45 6.72 9.40 7.90 9.90 7.34 0.32 
1462 14.85 12.45 8.16 8.64 8.14 9.04 8.40 8.48 7.90 7.22 9.54 
1475 14.85 12.45 6.12 8.98 18.30 16.90 18.60 20.10 14.06 9.45 8.09 
1481 14.85 12.45 8.16 8.64 12.30 11.20 8.91 8.14 9.48 6.78 9.78 
1483 23.70 17.60 10.20 9.32 7.80 7.56 5.91 13.30 12.90 14.90 12.60 
1484 14.85 4.66 6.99 6.78 6.66 6.08 3.22 4.52 6.12 7.72 4.03 
X 14.85 12.45 8.16 8.64 10.25 11.48 11.01 11.35 11.20 10.56 9.93 
SE 3.45 3.96 0.96 0.63 1.48 1.39 1.52 1.58 1.30 1.14 1.65 
Table 12. Progesterone concentration in peripheral plasma of Yorkshire gilts treated with 
PBS, ng/ml 
Gilt Day 
No -11 -10 -9 -8 -7 -6 -5 -4 -3 -2.5 -2 
1381 10.33 9.37 28.90 26.60 20.40 19.30 20.60 23.90 21.40 20.70 18.40 
1382 10.33 6.79 8.52 10.38 14.04 10.94 8.75 13.08 5.84 7.87 9.91 
1385 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
1430 13.80 18.40 11.70 6.56 6.58 7.96 10.50 12.30 8.69 9.20 5.97 
1444 10.33 9.37 12.60 8.84 13.40 6.83 7.52 5.64 4.34 4.54 4.24 
1445 10.33 9.37 12.80 8.08 14.40 9.84 6.34 10.90 4.90 10.90 4.73 
1450 6.87 1.71 3.72 5.18 3.17 1.31 3.64 2.56 1.90 1.51 0.75 
1454 10.33 10.60 9.97 11.20 12.40 9.98 14.80 17.50 5.17 11.00 6.87 
1485 10.33 9.37 12.60 10.98 12.06 9.45 9.12 5.52 7.87 12.40 11.20 
X 10.33 9.37 12.6 10.98 12.06 9.45 10.16 11.42 7.51 9.76 7.76 
SE 3.46 3.51 3.51 2.72 2.13 2.04 1.88 2.48 2.12 2.02 1.91 
138 
Day 
-2 -1.5 -1 -0.5 0 0.5 1 2 3 4 5 6 
9.44 9.49 3.20 2.47 1.62 0.70 0.98 1.76 0.81 0.18 0.12 0.28 
15.80 13.40 12.00 4.80 5.57 0.76 3.35 0.26 0.12 0.16 0.14 0.18 
18.10 12.40 4.04 1.92 1.24 0.80 0.22 0.08 0.07 0.08 0.18 0.23 
13.50 7.34 5.21 3.11 1.36 1.06 0.43 0.22 0.05 0.05 0.53 0.05 
4.24 3.65 3.84 2.50 1.06 0.38 0.10 0.12 0.14 0.19 0.14 0.05 
7.62 5.86 6.08 3.41 2.37 1.05 0.67 0.23 0.13 0.10 0.05 0.24 
13.30 12.30 11.10 6.30 2.62 1.27 0.80 1.20 0.30 0.30 0.11 0.38 
6.29 6.43 4.35 4.36 2.10 0.70 0.96 0.20 1.05 0.26 0.19 0.42 
11.80 5.00 2.94 3.58 1.44 1.18 0.40 0.47 0.47 0.32 0.18 0.23 
6.84 4.31 1.78 2.48 0.86 0.46 0.54 0.28 0.14 0.34 0.14 0.23 
10.69 8.02 5.45 3.49 2.02 0.84 0.84 0.48 0.33 0.20 0.18 0.23 
1.43 1.15 1.08 0.42 0.43 0.09 0.29 0.17 0.11 0.03 0.06 0.05 
Day 
-1.5 -1 -0.5 0 0.5 1 2 3 4 5 6 
18.30 8.36 6.34 3.46 2.60 0.72 0.21 0.18 0.24 0.09 0.43 
12.00 7.67 3.34 2.61 1.19 0.52 0.16 0.40 0.76 0.24 0.58 
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.76 
6.83 3.48 1.44 0.39 0.33 0.17 0.06 0.22 0.08 0.09 0.43 
7.04 4.19 0.88 0.56 0.05 0.05 0.05 0.05 0.05 0.05 0.48 
12.10 10.80 2.12 2.20 0.62 0.26 0.41 1.36 0.48 0.14 0.73 
0.88 0.10 0.04 0.04 0.05 0.05 0.03 0.03 0.03 0.02 0.02 
9.70 7.48 3.10 2.96 0.86 3.00 0.77 0.42 0.50 0.42 0.00 
11.60 4.58 2.75 0.51 0.37 0.70 0.08 6.37 0.36 0.12 0.00 
9.81 5.83 2.51 1.81 0.86 0.73 0.22 0.41 0.31 0.15 0.43 
1.8 1.19 0.68 0.49 0.32 0.34 0.09 0.15 0.09 0.04 0.16 
Table 13. Prolactin concentration in peripheral plasma of Yorkshire gilts treated with 
antipRLX540, ng/ml 
Day 
Gilt No. -11 -10 -9 -8 -7 -6 -5 -4 
1386 12.46 8.91 8.05 9.64 5.16 5.48 7.01 13.55 
1410 8.25 6.94 8.14 7.35 6.44 9.6 10.52 29.14 
1431 10.84 11.26 9.2 10.9 17.83 14.6 17.73 7.64 
1458 7.83 8.41 10.88 8.04 8.06 4.43 16.3 13.09 
1475 14.8 7.44 14.18 18.43 6.26 5.63 4.62 27.63 
X 10.84 8.59 10.09 10.87 8.75 7.95 11.24 18.21 
SE 1.64 0.86 1.67 2.02 1.61 1.66 2.05 5.32 
Table 14. Prolactin concentration in peripheral plasma of Yorkshire gilts treated with PBS, 
ng/ml 
Day 
Gilt No. -11 -10 -9 -8 -7 -6 -5 -4 
1381 15.6 13.12 12.43 16.75 14.17 11.6 10.46 48.44 
1444 6.86 14.03 10.5 11.89 8.05 17.85 12.65 42.2 
1450 6.29 6.26 19.36 16.46 8.09 15.37 13.06 20.67 
1382 12.56 12.39 13.84 12 14.49 8.95 10.62 9.83 
X 10.33 11.45 14.03 14.28 11.2 13.44 11.7 30.28 
SE 1.7 1.63 2.23 1.37 1.76 2.49 0.91 8.2 
140 
Day 
-3 -2 -1 0 1 2 3 4 5 6 
90.84 130.13 154.77 124.21 104.85 97.33 126.06 48.64 65.26 50.11 
49.18 42.8 70.21 72.13 0 61.9 34.27 71.2 64.77 19.07 
22.28 37.91 15.73 12.73 91.97 77.56 59.9 79.35 76.88 75.76 
29.59 33.73 58.45 65.15 69.05 65.47 59.97 27 49.08 35.2 
36.15 8.17 21.83 39.67 53.1 48.89 43.75 37.08 43.41 30.78 
32.42 36.58 53.4 51.21 62.85 61.54 57.7 46.47 49.08 35.2 
4.52 7.11 10.98 8.82 5.73 4.67 10.09 10.74 14.44 10.02 
Day 
-3 -2 -1 0 1 2 3 4 5 6 
0 0 0 0 0 0 0 0 0 0 
41.19 44.99 35.68 34.1 32.75 29.09 45.14 24.91 31.78 34.91 
32.94 12.88 19.19 14 5.05 10 11.27 30.37 58.31 47.91 
10.78 16.61 78.01 91.88 73.82 70.93 55.93 66.3 71.84 21.91 
37.72 36.08 46.72 49.45 41.24 38.36 36.95 40.55 53.98 34.91 
8.62 8.79 10.26 10.97 9.67 9 6.43 8.61 10.46 7.53 
Table 15. Relaxin in peripheral plasma of Meishan gilts during late pregnancy, ng/ml 
Minutes 
Gilt No. 0 20 40 60 80 100 120 140 160 180 
Dav 112 
254 2.69 1.86 2.2 2.55 2.66 2.68 2.6 2.47 8.32 3.29 
318 38.88 37 38.57 37.8 38.37 34.56 36.35 39.39 37.39 37.82 
333 39.86 36.97 41.03 37.86 43.88 35.46 43.83 41.67 38.95 45.94 
334 12.45 13.25 12.89 14.06 13.53 15.02 12.52 11.64 11.93 12.8 
Dav 113 
254 10.11 10.5 9.87 9.98 9.41 10.78 11.93 11.15 11.45 11.49 
318 49.57 50 43.08 45.86 40.31 41.17 40.15 39.28 37.29 34.91 
333 38.96 39.92 36.41 36.42 29.6 25.77 31.7 28.27 31.93 28.06 
334 31.38 26.76 28.99 35.55 40.13 36.03 36.1 37.2 32.78 27.76 
Day 114 
254 48.11 40.94 42.19 43.3 53.54 50.77 45.55 44.75 55.36 56.06 
318 1.34 1.47 1.3 1.23 1.38 1.21 1.34 1.18 1.05 1.14 
333 1.74 2.09 1.7 1.54 1.51 1.61 1.68 1.62 1.76 1.51 
334 58.56 45.8 50.58 49.59 46.24 48.67 47.86 41.47 28.74 36.13 
Dav 115 
254 85.31 81.24 95.51 118.65 102.7 93.91 72.89 84.54 90.35 79.82 
318 0.34 0.25 0.3 0.27 0.49 0.25 0.31 0.25 0.25 0.25 
333 0.31 0.51 0.73 0.62 0.37 0.47 0.54 0.55 0.39 0.58 
334 3.16 2.71 2.69 2.84 2.72 2.5 2.6 2.88 2.78 2.36 
Dav 116 
254 8.9 8.09 7.84 7.88 7.91 7 7.33 6.7 6.38 6.73 
318 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 
333 0.51 0.62 0.5 0.37 0.34 0.27 0.42 0.52 0.46 0.32 
334 0.64 0.56 0.76 0.6 0.59 0.62 0.28 0.77 0.69 0.75 
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Table 16. Relaxin in peripheral plasma of Meishan gilts after hysterectomy, ng/ml 
Minutes 
GihNo. 0 20 40 60 80 100 120 140 160 180 
Dav 112 
255 12.16 10.96 10.54 10.35 10.42 10.59 11.33 11.04 13.09 11.72 
212 10.47 11.81 12.11 14.4 14.18 13.08 15.11 12.6 15.04 15.48 
327 10.71 11.34 10.49 12.34 13.09 13.96 12.86 14.9 13.45 14.31 
495 16.37 16.89 16.27 16.51 16.51 16.51 16.51 16.51 16.51 16.51 
Day 113 
255 9.3 11.65 12.8 12.75 10.53 10.67 10.66 11.62 10.56 19.95 
272 19.74 19.07 20.48 22.37 21.38 23.59 22.42 22.06 20.41 23.29 
327 26.84 22.76 19.63 20.36 19.98 17.26 18.35 20.03 19.63 18.76 
495 11.89 15.66 15.63 13.2 15.87 16.65 18.96 14.66 14.1 13.8 
Dav 114 
255 26.59 21.59 16.86 17.1 13.64 14.19 14.15 12.74 14.33 5.48 
272 22.96 29.03 23.95 21.09 22.32 23.45 19.96 30.04 21.48 19.6 
327 24.32 22.74 23.88 24.18 25.59 24.87 23.53 19.49 18.53 19.23 
495 15.93 17.95 18.83 20.01 16.9 17.36 20.26 18.04 18.57 15.89 
Dav 115 
255 20.14 19.85 22.77 28.76 33.95 26.9 26.95 31.16 17.34 16 
272 29.25 27.37 24.44 21.51 25.28 21.08 24.74 20.48 21.07 21.66 
327 22.72 23 22.44 22.98 20.55 26.61 20.4 18.45 22.61 20.49 
495 12.64 12.91 12.39 16.66 37.95 14.97 14.21 14.82 14.92 15.5 
Dav 116 
255 7.04 12.36 9.68 11.21 17.52 22.3 13.35 13.35 13.35 13.35 
272 21.66 22.02 23.1 20.49 18.93 22.57 23.74 29.94 24.71 19.49 
327 19.48 21.98 29.97 20.64 23.26 24.04 24.98 21.17 19.46 23.38 
495 11.59 13.93 10.5 9.18 12.09 12.42 14.2 14.97 14.58 15.22 
Table 17. Progesterone in peripheral plasma of Meishan gilts during late pregnancy, ng/ml 
Minutes 
GiUNo. 0 20 40 60 80 100 120 140 160 180 
Dav 112 
254 38.34 33.4 31.76 30.97 20.48 18.95 21.42 22.5 28.34 14.06 
318 14.28 16.31 17.35 17.34 15.61 15.35 14.85 17.34 18.23 17.8 
333 10.98 12.08 13.13 16.76 17.18 18.66 18.58 6.2 17.15 10.33 
334 8.6 12.42 9.82 10.99 14.56 17.02 10.74 13.18 13.3 17.14 
Dav 113 
254 31.19 28.66 30.53 13.77 35.36 35.07 32.34 32.08 18.88 15.52 
318 8.7 9.88 9.75 7.78 7.38 8.55 7.32 7.57 7.41 7.97 
333 4.6 8.56 7.3 6.9 2.9 3.1 5.54 6.14 3.34 2.82 
334 10.47 5.44 12.73 12.76 9.74 11.48 7.21 8.9 7.78 8.14 
Dav 114 
254 33.2 37.27 32.7 25.12 37.65 38.43 31.8 34.66 41.56 37.54 
318 4.44 4.17 4.4 3.23 3.64 3.92 3.54 4.12 3.4 4.21 
333 1.03 0.39 1.62 1.12 0.62 1.99 1.45 1.34 1.08 1.97 
334 4.73 2.9 4.62 4.24 3.64 3.75 2.89 2.54 3.9 3.7 
Dav 115 
254 6.53 7.1 7.04 5.48 6.95 4.88 6.13 4.26 5.04 5.52 
318 1.72 2.36 1.85 2.1 2.29 2.08 1.86 2.25 2 1.78 
333 0.57 0.54 0.46 1.03 1.06 1.04 0.48 0.77 0.92 0.93 
334 1.74 1.93 2.02 2.42 1.59 1.46 1.56 1.09 1.74 1.6 
Dav 116 
254 2.3 3.12 3.04 3.26 2.86 4.06 2.8 2.78 3.22 2.89 
318 0.76 0.73 0.62 0.79 0.83 0.81 0.73 1.03 0.82 0.82 
333 0.65 0.68 0.5 0.54 0.84 0.67 0.48 0.59 0.63 0.84 
334 0.44 0.59 0.36 0.65 0.78 0.81 0.91 0.87 0.76 0.57 
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Table 18. Progesterone in peripheral plasma of Meishan gilts after hysterectomy, ng/ml 
Minutes 
Gilt No. 0 20 40 60 80 100 120 140 160 180 
Dav 112 
255 45.38 36.99 32.61 40.02 40.43 34.54 40.46 32.12 42.73 32.35 
272 33.78 35.06 40.3 42.28 40.39 41.91 27.54 27.72 29.92 35.76 
327 41.68 30.22 39.5 37.08 38.32 26.44 40.08 41.56 38.82 39.4 
495 12.04 9.33 10.04 9.06 11.63 7.4 12.36 15.8 9.06 9.4 
Dav 113 
255 38.42 43.48 47.42 40.52 44.18 49.34 44.21 34.59 37.02 47.96 
272 49.12 37.99 36.44 30.9 33.18 30.84 26.56 29.4 26.98 19.01 
327 47.38 45.94 38.54 25.52 29.94 33.74 23.84 22.68 17.36 40.24 
495 6.64 3.34 3.94 8.06 10.72 8.83 11.58 7.82 7.19 11.03 
Dav 114 
255 27.18 29.89 21.72 27.47 24.1 23.67 25.94 31.95 26.7 13.81 
272 16.26 33.08 28.13 21.92 28.26 26.68 36.21 37.68 37.24 21.18 
327 13.44 15.54 19.26 19.32 31.61 31.56 18.5 37.9 25.01 30.46 
495 11.92 15.15 8.56 12.64 12.75 12.3 9.54 11.41 7.04 16.04 
It 
115 
255 24.51 24.48 26.49 25.55 22.1 23.68 27.18 42.28 34.21 33.9 
272 21.02 28.02 21.86 23.88 23.34 26.05 33.76 31.08 22.26 25.1 
327 16.2 18.01 31.38 26.1 21.64 20.54 13.93 20.62 16.17 19.72 
495 5.24 10.56 5.42 9.92 10.28 4.4 8.4 6.38 9.44 9.98 
Dav 116 
255 42.14 43 48.37 39.71 46.7 44.32 32.3 38.99 32.82 41.26 
272 24.28 24.22 21.7 25.26 21.24 28.49 19.89 19,87 16.34 15.07 
327 16.7 17.8 10.3 12.12 12.08 15.94 20.96 17.88 13.64 23.72 
495 2.49 3.08 4.12 1.65 3.61 2.2 2.88 2.24 3.1 5.64 
Table 19. Prolactin in peripheral plasma of Meishan gilts during late pregnancy, ng/ml 
Minutes 
Gilt No 0 20 40 60 80 100 120 140 160 180 
Dav 112 
254 13.26 15.09 16.36 12.3 12.24 11.94 11.68 11.26 12.46 11.85 
318 28.67 28.44 25.44 30.47 29.04 30.9 27.84 25.29 28.82 23.92 
333 36.74 44.18 35.27 37.02 36.61 30.86 29.86 30.23 33.86 38.79 
334 16.66 13.85 12.49 20.36 23.16 23.48 20.27 16.04 16.85 18 
Dav 113 
254 12.6 15.11 12.46 12.71 12.74 11.83 11.7 10.81 12.33 10.96 
318 40.31 39.84 30.17 25.3 40.98 34.02 30.99 36.19 35.72 32.31 
333 58.07 77.51 68.15 60.48 66.2 64.31 54.85 63.31 72.04 74.49 
334 30.62 46.33 29.31 29.79 30.77 29.14 26.1 26.65 17.94 23.39 
D^y 114 
254 17.7 20.22 22.65 24.47 27.21 25.94 19.12 16.46 21.2 21.41 
318 46.9 54.21 34.03 36.57 47.16 36.58 42.25 43.91 33.1 40.88 
333 97.76 79.94 81.77 70.34 73.5 79.8 99.43 83.28 83.67 57.47 
334 26.75 34.04 31.27 36.44 40.81 39.74 36.84 39.3 37.91 48.3 
Dav 115 
254 68.53 80.01 68.2 91.82 77.43 57.12 95.82 76.71 99.47 99.34 
318 29.13 38.16 38.39 33.04 61.41 31.68 46.05 40.86 35.82 38.3 
333 80.86 55.7 103.2 101.5 90.27 94.72 68.16 79.86 54.3 79.78 
334 55.06 40.36 37.08 51.55 30.37 48.96 47.03 48.83 44.21 31.25 
Dav 116 
254 70.84 74.3 57.65 91.36 78.73 55.41 77.59 56.26 44.97 46.66 
318 40.34 36.77 37.94 34.06 29.55 27.11 24.24 34.17 24.44 30.01 
333 91.15 129.19 91.53 79.79 122.2 77.63 90.31 91.16 82.26 67.99 
334 37.78 27.69 56.09 51.2 27.59 28.27 30.36 33.31 27.88 38.49 
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Table 20. Prolactin in peripheral plasma of Meishan gilts after hysterectomy, ng/ml 
Minutes 
Gilt No. 0 20 40 60 80 100 120 140 160 180 
Dav 112 
255 6.78 6.85 5.9 5.4 5.9 5.74 5.99 5.96 6.28 5.38 
272 3.78 6.14 5.94 6.82 6.45 8.24 9.29 4.68 3.91 4.32 
327 4.37 4 4.9 4.03 4.56 4.3 5.55 5.15 4.25 4.39 
495 2.2 2.93 2.56 3.48 2.42 1.62 3.4 2.85 2.44 2.41 
Dav 113 
255 5.86 5.41 5.51 4.95 4.98 4.43 3.44 3.77 3.96 4.87 
272 5.57 3.87 4.38 4.8 5.07 4.65 4.48 8.81 5.29 16.22 
327 4.1 3.3 3.54 3.73 6.56 2.59 2.85 2.85 2.97 3.58 
495 3.22 2.76 3.05 2.24 3.42 3.29 2.02 2.6 3.95 2.11 
Dav 114 
255 5.35 5.11 4.88 4.42 4.88 4.11 4.98 5.91 6.11 4.64 
272 2.75 22.11 22.61 14.79 2.68 9.85 7.55 9.46 27.69 10.18 
327 2.83 2.14 2.38 2.86 2.66 2.63 2.53 2.24 2.93 2.9 
495 3.93 2.89 3.13 2.72 2.45 2.45 2.17 1.91 2.12 2.68 
Dav 115 
255 3.41 3.19 3.79 3.64 2.99 3.18 2.61 3.74 3.06 3.57 
272 7.56 9.57 17.34 4.25 9.73 8.55 9.21 9 6.78 11.04 
327 4.25 4.04 3.76 3.48 3.66 3.3 3.65 3.52 3.99 3.83 
495 6.22 5.06 4.45 3.09 2.7 2.74 3.09 3.53 3.03 2.54 
Dav 116 
255 2.31 3.83 3.33 2.83 3.09 3.2 3.49 4.45 4.43 4.75 
272 28.38 7.88 7.54 6.47 7.65 5.83 5.2 6.9 8.17 7.96 
327 4.75 5.06 3.63 3.45 4.13 5.87 3.73 2.51 3.13 4.16 
495 4.45 5.9 5.74 7.28 2.9 2.53 4.87 3.06 2.44 3.35 
Table 21. Growth hormone in peripheral plasma of Meishan gilts during late pregnancy, 
ng/ml 
Minutes 
Gilt No. 0 20 40 60 80 100 120 140 160 180 
Dav 112 
254 1.16 0.712 0.586 0.688 0.652 0.951 1.06 0.791 0.327 0.555 
318 0.639 0.342 0.474 0.764 0.438 0.445 0.295 0.806 0.732 0.325 
333 1.49 1.06 1.11 0.763 0.667 0.623 0.578 0.729 1.35 1.11 
334 0.65 0.76 1.04 0.777 0.635 0.498 0.694 0.561 0.511 0.591 
Dav 113 
254 1.17 1.01 0.737 0.917 0.524 1.34 0.484 0.655 0.622 0.608 
318 1.68 1.63 1.54 1.53 1.63 1.28 0.998 1.05 0.896 1.33 
333 0.971 0.732 0.86 0.903 0.886 0.846 1.14 0.849 0.936 0.63 
334 0.911 0.632 0.863 0.805 1.43 0.776 0.694 0.736 0.872 0.534 
Dav 114 
254 0.67 0.943 0.978 0.821 0.85 0.894 0.886 0.798 0.797 0.79 
318 0.894 0.805 0.679 0.56 0.887 0.793 0.559 1.14 0.435 0.458 
333 1.02 0.775 0.6 0.71 0.621 0.051 0.81 0.784 0.948 0.78 
334 0.999 0.864 1.86 1.96 0.593 1.09 1.58 2.18 1.54 1.32 
Dav 115 
254 0.5 0.895 1.53 0.799 1.03 0.666 0.867 0.051 0.654 0.873 
318 0.657 1.86 1.44 1.23 1.18 1.14 1.03 1.02 1.11 0.971 
333 2.76 2.84 2.12 1.94 1.26 1.11 0.941 0.966 1.09 1.21 
334 1.04 0.827 0.885 0.874 0.819 1.31 0.905 0.945 0.926 0.738 
Dav 116 
254 1.69 1.13 0.647 0.961 0.633 0.884 1.05 1.017 1.18 0.978 
318 2.12 0.937 1.29 1.08 1.29 1.4 1.43 1.55 1.33 1.62 
333 3.1 2.87 3.38 3.19 3.23 3.21 2.89 2.91 2.09 1.96 
334 1.66 1.39 1.44 1.64 1.92 1.65 1.47 1.82 1.3 1.59 
148 
Table 22. Growth hormone in peripheral plasma of Meishan gilts after hysterectomy, ng/ml 
Minutes 
Gilt No. 0 20 40 60 80 100 120 140 160 180 
Dav 112 
255 0.428 0.374 0.423 0.338 0.31 0.384 0.329 0.375 0.418 0.213 
272 0.897 1.33 1.03 1.27 1.17 1.11 0.945 0.81 0.858 0.854 
327 0.754 0.631 0.656 0.607 1.33 0.54 0.437 0.438 1.54 0.638 
495 1.12 0.757 0.818 0.898 0.898 0.898 0.898 0.898 0.898 0.898 
Dav 113 
255 1.14 0.571 0.432 0.338 0.759 0.475 0.571 0.347 0.184 0.52 
272 1.04 0.786 1.03 0.051 0.825 0.727 0.876 0.989 0.882 1.01 
327 0.833 0.514 0.577 0.394 0.59 0.383 0.493 0.536 0.516 0.303 
495 0.919 0.998 0.912 0.694 0.908 0.823 0.934 0.765 0.79 1.45 
Dav 114 
255 0.301 0.347 0.328 0.18 0.309 0.296 0.398 0.449 4.69 5.48 
272 0.74 0.855 1.49 1.09 1.01 0.733 0.871 0.91 0.795 0.726 
327 0.412 0.75 0.87 1.77 0.669 0.499 0.452 0.386 0.47 0.541 
495 0.554 0.407 0.37 0.46 0.551 0.906 0.522 0.814 0.542 0.666 
Dav 115 
255 2.55 2.45 0.32 0.23 0.189 0.419 0.412 0.939 0.939 0.939 
272 0.696 0.696 1.13 1.12 0.631 0.733 0.587 0.469 0.524 0.374 
327 0.401 1.27 0.63 1.1 0.726 0.539 0.576 0.449 0.751 0.352 
495 0.567 0.517 1.29 0.859 1.11 0.714 0.55 2.28 1.8 0.64 
Dav 116 
255 0.32 0.389 0.336 0.293 0.368 0.35 0.343 0.343 0.343 0.343 
272 0.776 1.12 1.24 0.984 0.7 0.55 0.553 0.487 0.745 0.296 
327 0.468 0.409 0.467 0.384 2.36 0.512 0.739 0.525 0.534 0.951 
495 1.3 0.662 0.575 0.63 1.21 1.38 0.835 0.443 0.698 0.701 
